<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23071718</article-id><article-id pub-id-type="pmc">3465282</article-id><article-id pub-id-type="publisher-id">PONE-D-12-04256</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0047079</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Cardiovascular</subject><subj-group><subject>Cardiovascular Diseases in Women</subject></subj-group></subj-group><subj-group><subject>Clinical Immunology</subject><subj-group><subject>Immunity</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group><subj-group><subject>Endocrinology</subject><subj-group><subject>Endocrine Physiology</subject><subj-group><subject>Hormones</subject></subj-group></subj-group></subj-group><subj-group><subject>Nutrition</subject><subj-group><subject>Obesity</subject></subj-group></subj-group><subj-group><subject>Public Health</subject><subj-group><subject>Preventive Medicine</subject></subj-group></subj-group><subj-group><subject>Sports and Exercise Medicine</subject></subj-group></subj-group></article-categories><title-group><article-title>Effect of Modest Caloric Restriction on Oxidative Stress in Women, a Randomized Trial</article-title><alt-title alt-title-type="running-head">Oxidative Stress in Caloric Restriction</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Buchowski</surname><given-names>Maciej S.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hongu</surname><given-names>Nobuko</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Acra</surname><given-names>Sari</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Warolin</surname><given-names>Joshua</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Roberts</surname><given-names>L. Jackson</given-names><suffix>II</suffix></name><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Department of Nutritional Sciences, University of Arizona, Tucson, Arizona, United States of America</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Department of Pediatrics, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America</addr-line>
</aff><aff id="aff5">
<label>5</label>
<addr-line>Department of Medicine, Department of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Einwaechter</surname><given-names>Henrik</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>Klinikum rechts der Isar der TU M&#x000fc;nchen, Germany</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>maciej.buchowski@vanderbilt.edu</email></corresp><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: MSB NH LJR. Performed the experiments: MSB LJR. Analyzed the data: MSB NH JW SA LJR LW. Contributed reagents/materials/analysis tools: NH. Wrote the paper: MSB JW SA LJR LW.</p></fn></author-notes><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>5</day><month>10</month><year>2012</year></pub-date><volume>7</volume><issue>10</issue><elocation-id>e47079</elocation-id><history><date date-type="received"><day>30</day><month>1</month><year>2012</year></date><date date-type="accepted"><day>11</day><month>9</month><year>2012</year></date></history><permissions><copyright-statement>&#x000a9; 2012 Buchowski et al</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>Buchowski et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec><title>Objectives</title><p>It is not established to what extent caloric intake must be reduced to lower oxidative stress in humans. The aim of this study was to determine the effect of short-term, moderate caloric restriction on markers of oxidative stress and inflammation in overweight and obese premenopausal women.</p></sec><sec><title>Materials/Methods</title><p>Randomized trial comparison of 25% caloric restriction (CR) or control diet in 40 overweight or obese women (body mass index 32&#x000b1;5.8 kg/m<sup>2</sup>) observed for 28 days and followed for the next 90 days. Weight, anthropometry, validated markers of oxidative stress (F<sub>2</sub>-isoprostane) and inflammation (C-reactive protein), adipokines, hormones, lipids, interleukins, and blood pressure were assessed at baseline, during the intervention, and at follow-up.</p></sec><sec><title>Results</title><p>Baseline median F<sub>2</sub>-isoprostane concentration (57.0, IQR&#x0200a;=&#x0200a;40.5&#x02013;79.5) in the CR group was 1.75-fold above average range for normal weight women (32.5 pg/ml). After starting of the caloric restriction diet, F<sub>2</sub>-isoprostane levels fell rapidly in the CR group, reaching statistical difference from the control group by day 5 (median 33.5, IQR&#x0200a;=&#x0200a;26.0&#x02013;48.0, P&#x0003c;0.001) and remained suppressed while continuing on the caloric restriction diet. Three months after resuming a habitual diet, concentrations of F<sub>2</sub>-isoprostane returned to baseline elevated levels in &#x0223c;80% of the women.</p></sec><sec><title>Conclusions</title><p>Oxidative stress can be rapidly reduced and sustained through a modest reduction in caloric intake suggesting potential health benefits in overweight and obese women.</p></sec><sec><title>Trial Registration</title><p>Clinicaltrials.gov <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov/ct2/show/NCT00808275">NCT00808275</ext-link>
</p></sec></abstract><funding-group><funding-statement>MSB was supported in part by grant DK020593, from the National Institutes of Health (NIH). Funding and/or programmatic support has been provided by Vanderbilt Clinical and Translational Science Award (CTSA) grant 1UL1 RR024975 from the National Center for Research Resources, and Vanderbilt Diabetes Research and Training Center grant DK069465, National Institute of Health. Additional support came from a NIH MERIT Award (GM42056) awarded to LJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="10"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Obesity is associated with increased oxidative stress and chronic low-grade chronic inflammation <xref rid="pone.0047079-Vincent1" ref-type="bibr">[1]</xref>&#x02013;<xref rid="pone.0047079-Basu1" ref-type="bibr">[4]</xref>. Both events contribute to metabolic abnormalities occurring in the obesity-associated metabolic syndrome <xref rid="pone.0047079-Vincent1" ref-type="bibr">[1]</xref>, <xref rid="pone.0047079-Furukawa1" ref-type="bibr">[5]</xref>&#x02013;<xref rid="pone.0047079-Ouchi1" ref-type="bibr">[7]</xref> and play a critical role in the pathogenesis of various diseases such as atherosclerosis <xref rid="pone.0047079-Keaney1" ref-type="bibr">[8]</xref>, <xref rid="pone.0047079-Sawyer1" ref-type="bibr">[9]</xref>, cancer <xref rid="pone.0047079-Barocas1" ref-type="bibr">[10]</xref>, <xref rid="pone.0047079-DeMarzo1" ref-type="bibr">[11]</xref>, cardiovascular disease <xref rid="pone.0047079-Couillard1" ref-type="bibr">[12]</xref>, and diabetes type 2 <xref rid="pone.0047079-Helmersson1" ref-type="bibr">[13]</xref>. Recent research has shown that weight loss attenuates inflammation and leads to improvement in adipokine profiles <xref rid="pone.0047079-Tchernof1" ref-type="bibr">[14]</xref>&#x02013;<xref rid="pone.0047079-Rolland1" ref-type="bibr">[16]</xref>. Although associations of overweight and obesity with increased oxidative stress have been reported, the effects of weight loss on oxidative stress markers are rarely described in literature <xref rid="pone.0047079-Meydani1" ref-type="bibr">[17]</xref>. Moreover, many clinical studies and intervention studies with diets or supplements have employed single measurements of F<sub>2</sub>-isoprostane before and after the intervention to estimate the oxidative stress without exploring intermittent or interval changes. To our knowledge, no prior study has investigated the association between caloric restriction (CR) and systemic short-term changes in markers of oxidative stress.</p><p>Thus, the goal of this controlled clinical trial was to determine whether modest (25%) short-term caloric restriction-induced weight loss affects systemic oxidative stress, as measured by changes in serum F<sub>2</sub>-isoprostane.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><p>The protocol for this trial and supporting CONSORT checklist are available as supporting information; see <xref ref-type="supplementary-material" rid="pone.0047079.s001">Checklist S1</xref> and <xref ref-type="supplementary-material" rid="pone.0047079.s002">Protocol S1</xref>. The protocol flow diagram is in <xref ref-type="fig" rid="pone-0047079-g001">Figure 1</xref>.</p><fig id="pone-0047079-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0047079.g001</object-id><label>Figure 1</label><caption><title>CONSORT flow diagram.</title></caption><graphic xlink:href="pone.0047079.g001"/></fig><sec id="s2a"><title>Subjects</title><p>Forty premenopausal overweight and obese women, (18- to 45-years-old; body mass index - BMI: 25.4 to 43.0 kg/m<sup>2</sup>), were recruited from Nashville&#x02019;s general population by advertisement in Vanderbilt University&#x02019;s newspaper, mass emails, and flyers. Inclusion criteria were BMI more than 25 kg/m<sup>2</sup> and willingness to abstain from alcohol consumption for the duration of the study, complete an overnight stay at the Clinical Research Center (CRC), and come to the CRC daily to obtain study foods. Volunteers were excluded if they reported having clinically significant illnesses (including type 2 diabetes), smokers, taking lipid-lowering medications, reported recent initiation/change in hormonal birth control or hormone replacement therapy, pregnant or lactating, taking medications or dietary supplements that affect body weight, or regularly engaging in vigorous physical activities. Participants classified their own ethnicity according to investigator-defined options. At a screening visit, all volunteers were measured for height, weight, and waist circumference, and completed a lifestyle questionnaire. Approximately 150 women were screened for eligibility based on the above criteria and 40 were enrolled. All applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during this research, in accordance with the ethical principles of the Helsinki-II Declaration. The trial (Clinicaltrials.gov Identifier: NCT00808275) was approved by the Institutional Review Board at Vanderbilt University and all participants provided written informed consent.</p></sec><sec id="s2b"><title>Study Design</title><p>The study consisted of an experimental group that received a CR diet and a control group that remained on a habitual diet throughout the study. The ratio of women in CR group to the control group was 4 to 1 (allocated via blocked randomization by a statistician not involved in patient recruitment). The study was divided into a 7-day lead in period (Day -6 to Day 0), immediately followed by a 28-day intervention (Day 1 to Day 28), and a 3-month follow-up (Day 29 to Day 118). Dietary intervention in the CR group started during the luteal stage of the menstrual cycle (14&#x02013;24 d) to control for confounding by menstrual cycle and any associated oxidative and/or inflammatory stress.</p></sec><sec id="s2c"><title>Anthropometrics and Body Composition</title><p>The National Health and Nutrition Examination Survey (NHANES) protocols were followed for all anthropometrical measurements <xref rid="pone.0047079-1" ref-type="bibr">[18]</xref>. Body weight was measured at baseline and daily (for the experimental group) within 0.1 kg using a calibrated beam platform scale (Detecto-Medic, Detecto Scales, Inc, Northbrook, IL). Daily weight measurements were not revealed to participants and served as the criterion measure for dietary adherence. Height was measured at baseline within 0.5 cm using a calibrated wall-mounted stadiometer (Perspective Enterprises, Portage, MI). The average of two readings was used for analysis. All measurements were performed by the same investigator. Body composition (including fat mass and fat free mass) was measured at baseline (Day 0), during intervention (Days 14 and 28), and during the follow up visits (Days 42 and 119) using dual energy x-ray absorptiometry Lunar instrument (Lunar Prodigy, GE Medical Systems, Madison WI, adult software v. 9.15). For quality assurance and equilibration, a calibration block was scanned each morning and a spine phantom was scanned on a weekly basis (the coefficient of variation was 0.7%).</p></sec><sec id="s2d"><title>Resting Energy Expenditure (REE)</title><p>REE was measured at Day 0 and 29 and was defined as the average EE during a 30-min period of lying in a supine position after a 30-min rest following an overnight fast (&#x0003e;10 h) using a whole-room indirect calorimeter. REE was calculated from measured rates of oxygen (O<sub>2</sub>) consumption and carbon dioxide (CO<sub>2</sub>) production using Weir&#x02019;s equation <xref rid="pone.0047079-Weir1" ref-type="bibr">[19]</xref>. The accuracy and precision of our metabolic chamber for measuring EE as determined by routine alcohol combustion test was 99.7% (IQR&#x0200a;=&#x0200a;99.5&#x02212;100.0%) over 24 hours and 98.5% (IQR&#x0200a;=&#x0200a;96.9&#x02013;99.9%) over 30 minutes.</p></sec><sec id="s2e"><title>Dietary Intake</title><sec id="s2e1"><title>Caloric restriction diet</title><p>Participants in the CR group received individualized energy and nutrient controlled diets provided by the CRC metabolic kitchen for consumption at home. Energy needs were calculated as the sum of resting energy expenditure (REE) and energy expenditure of physical activity. Thermic effect of food was estimated as 10% of REE. Each individualized diet, provided in daily portions divided into 3 meals and 3 snacks, contained approximately 75% (&#x000b1;210 kcal) of daily energy requirements, including 52&#x02013;62% of energy from carbohydrates, 25&#x02013;29% of energy from fat, 18&#x02013;23% of energy from protein, and 22&#x02013;27 g of fiber. All participants received a multivitamin supplement daily (Nature Made, Mission Hills, CA). No restrictions were imposed on the amounts of energy-free foods ingested. Each participant received a written list of foods at daily pick-up. Any uneaten foods and any additional foods eaten by the participants were reported on sheets collected daily. The study dietitian met with each participant weekly to discuss the diet, resolve any barriers or concerns related to food or specimen collection, and encourage compliance. Energy and nutrient intake calculations were performed using the Nutrient Data System for Research (NDSR) software version 2009 developed by the Nutrition Coordinating Center, University of Minnesota, Minneapolis, MN, Food and Nutrient Database <xref rid="pone.0047079-Miller1" ref-type="bibr">[20]</xref>, <xref rid="pone.0047079-Harnack1" ref-type="bibr">[21]</xref>. Adherence to the protocol was monitored by urinary biomarkers (sodium, potassium, nitrogen) <xref rid="pone.0047079-Bingham1" ref-type="bibr">[22]</xref>, <xref rid="pone.0047079-McCullough1" ref-type="bibr">[23]</xref>.</p></sec><sec id="s2e2"><title>Control diet</title><p>Participants in the control group were asked to follow their habitual diet for the study duration and they received a multivitamin supplement daily (Nature Made, Mission Hills, CA). Their dietary intake was assessed during the intervention (Days 1&#x02013;28) from three 24-dietary recalls (2 weekdays and 1 weekend day) performed using automated multi-pass method and NDS-R software <xref rid="pone.0047079-Feskanich1" ref-type="bibr">[24]</xref>, <xref rid="pone.0047079-Johnson1" ref-type="bibr">[25]</xref>.</p></sec></sec><sec id="s2f"><title>Physical Activity</title><p>Daily physical activity was assessed using an RT3 accelerometer (StayHealthy, Monrovia, CA, US). Participants were instructed to maintain their habitual physical activity level and wore an activity monitor on their right hip while awake for the duration of the intervention and twice for 7 days during the follow-up. Total and physical activity energy expenditure was calculated using energy calculated from the monitor-measured movement and measured REE. Physical activity levels (PAL) for each monitored day were calculated by dividing total energy expenditure by REE.</p></sec><sec id="s2g"><title>Blood Pressure</title><p>Blood pressure was measured 3 times a week in the reclining position after 10 min rest with automatically inflating cuff (Dynamap, General Electric, Milwaukee, WI, USA) using a standard protocol.</p></sec><sec id="s2h"><title>Blood Collection and Biochemical Measurements</title><p>Venous blood samples were drawn after an overnight fast at baseline and on days 1, 3, 5, 7, 14, 21, 29, 42, and 119, centrifuged immediately at 1 000 g for 10 minutes at 4&#x000b0;C, and the serum was stored in cryovials at &#x02013;80&#x000b0;C until the assays were performed in batches. Samples obtained at baseline and during the study for each participant were included in the same assay run to avoid inter-assay variability among participants. F<sub>2</sub>-isoprostane was analyzed using gas chromatography/mass spectrometry (GC/MS), a previously described and validated method <xref rid="pone.0047079-Morrow1" ref-type="bibr">[26]</xref> with outstanding performance characteristics <xref rid="pone.0047079-Kadiiska1" ref-type="bibr">[27]</xref>, <xref rid="pone.0047079-Milne1" ref-type="bibr">[28]</xref>. F<sub>2</sub>-isoprostane assessing oxidation of lipids <xref rid="pone.0047079-Morrow2" ref-type="bibr">[29]</xref> has been shown to provide one of the most accurate assessments of oxidative stress status <xref rid="pone.0047079-Kadiiska1" ref-type="bibr">[27]</xref>, <xref rid="pone.0047079-Milne2" ref-type="bibr">[30]</xref>. Other methods (not used in this study) are targeting protein oxidation by measuring carbonyl groups in serum <xref rid="pone.0047079-Chevion1" ref-type="bibr">[31]</xref>, DNA damage by measuring hydroxyl radical-induced products of DNA bases <xref rid="pone.0047079-Dizdaroglu1" ref-type="bibr">[32]</xref>, and activity of several antioxidative enzymes including catalase, superoxide dismutase (SOD), glutathione S-transferase, and glutathione peroxidase (GPx) <xref rid="pone.0047079-Koizumi1" ref-type="bibr">[33]</xref>&#x02013;<xref rid="pone.0047079-Gomi1" ref-type="bibr">[35]</xref>.</p><p>A basic metabolic panel, hematological indices (hemoglobin concentration, hematocrit, red and white blood cell counts), and C-reactive protein were analyzed in the Vanderbilt University Hospital Laboratory using standard methodologies. Blood for measurement of lipids, inflammatory cytokines, and hormones (leptin, insulin, adiponectin) was centrifuged, serum was extracted, and the samples were stored at &#x02212;80&#x000b0;C until later analyses. Plasma triglyceride (TG), total cholesterol (TC), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) levels were measured using enzymatic kits from Cliniqa Corporation (San Marcos, CA). Free fatty acids (FFA) were measured using the NEFA-C kit by Wako (Nneuss, Germany) and by gas chromatography. Glucose was measured using the Vitros Chemistry analyzer. Insulin and leptin measurements were performed using RIAs. Adiponectin was measured using a kit from Millipore (Billerica, MA) and Luminex multiplexing technology.</p></sec><sec id="s2i"><title>Urine Collection and Analyses</title><p>Complete 24-h urine samples were collected once weekly. Urine volume and density was measured and a 10 mL sample was frozen at &#x02212;70&#x000b0;C until further analysis. Urinary calcium, sodium, and potassium were measured using Vitros 250 Analyzer (Ortho-Clinical Diagnostics, Rochester, NY, USA). Urinary nitrogen content was measured using nitrogen analyzer (Antek Instrument Nitrogen System 9000NS, Antek Instruments, Inc., Houston, TX, USA). The nitrogen excretion in the urine was used as a biological marker for protein intake by multiplying the content of nitrogen in the urine by the factor 7.72 <xref rid="pone.0047079-Bingham1" ref-type="bibr">[22]</xref>. The urine sodium and potassium contents were used as biological markers of sodium and potassium intake, respectively. Urinary creatinine was measured on a Sirrus Clinical Chemistry analyzer (Stanbio Laboratory, Boerne, TX).</p></sec><sec id="s2j"><title>Statistical Analysis</title><p>Descriptive statistics were presented as mean and standard deviation (SD) or median and IQR or percentage, as appropriate. Daily caloric intake and REE were expressed as the absolute and deficit number of kilocalories per day. Continuous endpoints were compared between the control and intervention group using Wilcoxon rank sum test. The change within group was assessed using Wilcoxon signed rank test. Spearman correlation coefficient was used to assess the correlation between two continuous variables. Multivariable linear model was used to assess the treatment effect at single time point while adjusting for the baseline measures. We performed a linear model using generalized least squares with autocorrelation structure of order 1 (AR1) for the within-subject correlation to assess the F<sub>2</sub>-isoprostane change within 28 days of study period. The main effects included baseline age, BMI, and F<sub>2</sub>-isoprostane, time, group, and time by group interaction. Time was modeled as nonlinear relationship to the F<sub>2</sub>-isoprostane using restricted cubic splines. Residual plot and quantile-quantile (QQ) plots were used to check the model assumptions. The level of statistical significance was set at p&#x0003c;0.05. All analyses were done with STATA 11 (StataCorp, College Station, TX) and the statistical programming language R, version 2.13.1 (R Development Core Team, Vienna, Austria).</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Baseline Characteristics and Compliance</title><p>Thirty of 32 participants in the CR group and all controls completed the intervention part of the study (i.e., returned for the Day 29 visit). The reasons for study dropout were work related (n&#x0200a;=&#x0200a;1) and a family emergency (n&#x0200a;=&#x0200a;1). Twenty-six CR and 7 control group participants completed the entire study. The reasons for study dropout were work-related (CR, n&#x0200a;=&#x0200a;2; control, n&#x0200a;=&#x0200a;1), pregnancy (CR, n&#x0200a;=&#x0200a;1), and an unspecified reason (CR, n&#x0200a;=&#x0200a;1). The participants who did not complete the CR protocol did not differ from the completers in regards to age, body weight, body fat, CRP, or insulin, but did have lower baseline F<sub>2</sub>-isoprostane plasma concentrations (38.5, IQR&#x0200a;=&#x0200a;20.5&#x02013;48.2 vs. 63.5, IQR&#x0200a;=&#x0200a;45.8&#x02013;79.0; P&#x0200a;=&#x0200a;0.01). Baseline demographic and anthropometric characteristics are shown in <xref ref-type="table" rid="pone-0047079-t001">Table 1</xref>. Adherence to the protocol in completers was good as measured by urinary biomarkers calculated as ratios of reported intake and excretion for protein (1.03&#x000b1;0.25), sodium (0.95&#x000b1;0.19) and potassium (1.04&#x000b1;0.32) (<xref ref-type="table" rid="pone-0047079-t002">Table 2</xref>).</p><table-wrap id="pone-0047079-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0047079.t001</object-id><label>Table 1</label><caption><title>Baseline demographic and anthropometric characteristics.</title></caption><alternatives><graphic id="pone-0047079-t001-1" xlink:href="pone.0047079.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Control diet (n&#x0200a;=&#x0200a;8)</td><td align="left" rowspan="1" colspan="1">CR diet (n&#x0200a;=&#x0200a;32)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1">29.5 (26.8&#x02013;33.3)</td><td align="left" rowspan="1" colspan="1">30.5 (26.0&#x02013;34.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Body weight (kg)</td><td align="left" rowspan="1" colspan="1">86.9 (72.2&#x02013;96.2)</td><td align="left" rowspan="1" colspan="1">85.2 (70.4&#x02013;99.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Body-mass index (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">30.1 (28.1&#x02013;38.3)</td><td align="left" rowspan="1" colspan="1">32.3 (26.6&#x02013;36.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Body fat mass (kg)</td><td align="left" rowspan="1" colspan="1">39.3 (33.2&#x02013;44.1)</td><td align="left" rowspan="1" colspan="1">38.6 (27.5&#x02013;49.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Ethnicity</italic>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">African American</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">9</td></tr><tr><td align="left" rowspan="1" colspan="1">Caucasian</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">22</td></tr><tr><td align="left" rowspan="1" colspan="1">Other (Asian, Hispanic)</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><p>Data are presented as median (interquartile range - IQR).</p></fn><fn id="nt102"><p>Abbreviations: CR diet, caloric restriction diet.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0047079-t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0047079.t002</object-id><label>Table 2</label><caption><title>Comparison of reported average (28 days) intake of protein, sodium, and potassium with the corresponding biological markers in urine in the caloric restriction (CR) diet group.</title></caption><alternatives><graphic id="pone-0047079-t002-2" xlink:href="pone.0047079.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Intake<xref ref-type="table-fn" rid="nt104">a</xref>
</td><td align="left" rowspan="1" colspan="1">Urinary Excretion<xref ref-type="table-fn" rid="nt105">b</xref>
</td><td align="left" rowspan="1" colspan="1">Ratio of Intake to Excretion</td><td align="left" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="nt106">c</xref>
</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Protein (g/day)</td><td align="left" rowspan="1" colspan="1">85.0&#x000b1;12.0</td><td align="left" rowspan="1" colspan="1">87.9&#x000b1;3.6</td><td align="left" rowspan="1" colspan="1">1.03&#x000b1;0.25</td><td align="left" rowspan="1" colspan="1">0.486</td></tr><tr><td align="left" rowspan="1" colspan="1">Sodium (g/day)</td><td align="left" rowspan="1" colspan="1">3.03&#x000b1;0.44</td><td align="left" rowspan="1" colspan="1">3.18&#x000b1;0.83</td><td align="left" rowspan="1" colspan="1">0.95&#x000b1;0.19</td><td align="left" rowspan="1" colspan="1">0.919</td></tr><tr><td align="left" rowspan="1" colspan="1">Potassium (g/day)</td><td align="left" rowspan="1" colspan="1">2.93&#x000b1;0.43</td><td align="left" rowspan="1" colspan="1">2.83&#x000b1;0.43</td><td align="left" rowspan="1" colspan="1">1.04&#x000b1;0.32</td><td align="left" rowspan="1" colspan="1">0.553</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><p>Data are presented as means &#x000b1; s.d.</p></fn><fn id="nt104"><label>a</label><p>Average daily intakes of protein, sodium, and potassium assessed by NDSR (Nutrition Diet System, St. Paul, MN).</p></fn><fn id="nt105"><label>b</label><p>Excretion measured from 4 weekly 24-hour urine collections. Protein&#x0200a;=&#x0200a;urinary nitrogen *7.72 (18), Potassium&#x0200a;=&#x0200a;urinary potassium *0.77 (19).</p></fn><fn id="nt106"><label>c</label><p>Comparison of ratios of intake to excretion; one sample t-test.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b"><title>Changes in F<sub>2</sub>-isoprostane Concentrations</title><p>We fit a linear model of F<sub>2</sub>-isoprostane within the 28 days study period using generalized least squares. F<sub>2</sub>-isoprostane was log transformed since the distribution was skewed. There were statistically significant differences between the CR and control group (P&#x0003c;0.001). The biggest difference appeared at day 14 (control/CR, 1.79, 95% CI: 1.50&#x02013;2.13) and day 21 (control/CR, 1.82, 95% CI: 1.56&#x02013;2.11). (<xref ref-type="fig" rid="pone-0047079-g002">Figure 2</xref>, <xref ref-type="table" rid="pone-0047079-t003">Table 3</xref>). In participants with BMI&#x0003e;30 (n&#x0200a;=&#x0200a;14), plasma F<sub>2</sub>-isoprostane concentrations decreased by more than 50% during the first week (Day 1 to Day 7). After the 3-month follow-up period, plasma F<sub>2</sub>-isoprostane concentrations in the CR group increased and the difference between the groups was not significant (P&#x0200a;=&#x0200a;0.692) (<xref ref-type="table" rid="pone-0047079-t004">Table 4</xref>).</p><fig id="pone-0047079-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0047079.g002</object-id><label>Figure 2</label><caption><title>Median plasma concentrations of F<sub>2</sub>-isoprostane (prostaglandin F<sub>2</sub>-like compound) in overweight and obese women at baseline (Day 0), during dietary intervention (Days 1&#x02013;29), and after 90-day follow-up (Days 42 and 119) in the CR (caloric restricted) diet (75% of energy requirement) group (n&#x0200a;=&#x0200a;32) and in the control group (n&#x0200a;=&#x0200a;8) without diet restrictions (100% of energy requirement).</title><p>Vertical bars represent 95% bootstrap confidence intervals.</p></caption><graphic xlink:href="pone.0047079.g002"/></fig><table-wrap id="pone-0047079-t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0047079.t003</object-id><label>Table 3</label><caption><title>Multivariable linear regression results for change in F2-isoprostane serum levels during the 28-day dietary intervention.</title></caption><alternatives><graphic id="pone-0047079-t003-3" xlink:href="pone.0047079.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Factor</td><td align="left" rowspan="1" colspan="1">Effect</td><td align="left" rowspan="1" colspan="1">95% CI</td><td align="left" rowspan="1" colspan="1">p-value</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Baseline age [years] - 34&#x02236;26</td><td align="left" rowspan="1" colspan="1">0.95</td><td align="left" rowspan="1" colspan="1">0.89&#x02013;1.02</td><td align="left" rowspan="1" colspan="1">0.150</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline BMI [kg/m<sup>2</sup>] - 36.4&#x02236;26.9</td><td align="left" rowspan="1" colspan="1">1.12</td><td align="left" rowspan="1" colspan="1">1.02&#x02013;1.21</td><td align="left" rowspan="1" colspan="1">0.015</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline F<sub>2</sub>-isoprostane (pg/mL) - 78.2&#x02236;44.8</td><td align="left" rowspan="1" colspan="1">1.46</td><td align="left" rowspan="1" colspan="1">1.36&#x02013;1.55</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Day of intervention - day 21:day 3</td><td align="left" rowspan="1" colspan="1">0.76</td><td align="left" rowspan="1" colspan="1">0.69&#x02013;0.84</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Group - Control : CR</td><td align="left" rowspan="1" colspan="1">1.60</td><td align="left" rowspan="1" colspan="1">1.36&#x02013;1.88</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt107"><p>Effect shown is the F<sub>2</sub>-isoprostane ratio. BMI - body mass index; CR diet- caloric restriction diet. Adjusted to: Day of intervention&#x0200a;=&#x0200a;7, Group&#x0200a;=&#x0200a;CR.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0047079-t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0047079.t004</object-id><label>Table 4</label><caption><title>Differences in F<sub>2</sub>-isoprostane (pg/mL) serum levels between caloric restriction (CR) and control groups at baseline (Day 0), during the intervention (Days 1 to 29), and follow-up (Days 42 and 119).</title></caption><alternatives><graphic id="pone-0047079-t004-4" xlink:href="pone.0047079.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Time</td><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">Control diet</td><td align="left" rowspan="1" colspan="1">CR diet</td><td align="left" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="nt109">a</xref>
</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">61.0 (51.8&#x02013;65.0)</td><td align="left" rowspan="1" colspan="1">57.0 (40.5&#x02013;79.5)</td><td align="left" rowspan="1" colspan="1">0.908</td></tr><tr><td align="left" rowspan="1" colspan="1">Day 1</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">55.0 (48.8&#x02013;65.0)</td><td align="left" rowspan="1" colspan="1">44.0 (35.5&#x02013;61.2)</td><td align="left" rowspan="1" colspan="1">0.153</td></tr><tr><td align="left" rowspan="1" colspan="1">Day 3</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">56.0 (46.8&#x02013;73.5)</td><td align="left" rowspan="1" colspan="1">39.5 (24.8&#x02013;50.2)</td><td align="left" rowspan="1" colspan="1">0.010</td></tr><tr><td align="left" rowspan="1" colspan="1">Day 5</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">62.5 (45.0&#x02013;72.5)</td><td align="left" rowspan="1" colspan="1">33.5 (26.0&#x02013;48.0)</td><td align="left" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Day 7</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">52.0 (45.0&#x02013;66.0)</td><td align="left" rowspan="1" colspan="1">33.5 (23.8&#x02013;45.8)</td><td align="left" rowspan="1" colspan="1">0.007</td></tr><tr><td align="left" rowspan="1" colspan="1">Day 14</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">50.0 (42.0&#x02013;67.5)</td><td align="left" rowspan="1" colspan="1">34.0 (23.5&#x02013;43.5)</td><td align="left" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">Day 21</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">58.0 (49.2&#x02013;60.2)</td><td align="left" rowspan="1" colspan="1">30.5 (23.8&#x02013;42.5)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">38</td><td align="left" rowspan="1" colspan="1">51.0 (49.2&#x02013;53.5)</td><td align="left" rowspan="1" colspan="1">29.5 (23.2&#x02013;40.8)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Day 42</td><td align="left" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">61.0 (55.0&#x02013;65.0)</td><td align="left" rowspan="1" colspan="1">33.5 (29.0&#x02013;53.5)</td><td align="left" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">56.0 (52.0&#x02013;59.5)</td><td align="left" rowspan="1" colspan="1">56.0 (36.0&#x02013;66.0)</td><td align="left" rowspan="1" colspan="1">0.692</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt108"><p>Data are presented as median (interquartile range- IQR). CR diet, caloric restriction diet.</p></fn><fn id="nt109"><label>a</label><p>Wilcoxon rank sum test for differences between Control and CR diets.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3c"><title>Energy Balance and Weight Changes</title><p>The average caloric intake was significantly lower in the CR than in the control group with an average intake of 17.8&#x000b1;2.2 kcal/kg/day vs. 28.2&#x000b1;4.6 kcal/kg/day (P&#x0003c;0.001). By the end of the dietary intervention (Day 29), total body weight and body fat weight decreased in the CR more than in the control group (difference 2.7 kg and 1.1 kg, respectively). However, differences in body weight and body fat between CR and control groups were non-significant at baseline, end of intervention, and day 119 follow-up (<xref ref-type="table" rid="pone-0047079-t005">Table 5</xref>). There was no significant between group difference in REE adjusted for fat free mass. The total amount of physical activity-related EE (kcal/day) was lower in the CR than the control group at Day 29 (difference of 61.2 kcal/day, P&#x0200a;=&#x0200a;0.057). However, there was no significant between group difference (P&#x0200a;=&#x0200a;0.303) in physical activity level (PAL) at the end of the intervention period (<xref ref-type="table" rid="pone-0047079-t006">Table 6</xref>). Median intake of energy and macronutrients was lower in the CR than in control group (P&#x0003c;0.001), as expected (<xref ref-type="table" rid="pone-0047079-t007">Table 7</xref>).</p><table-wrap id="pone-0047079-t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0047079.t005</object-id><label>Table 5</label><caption><title>Body weight, BMI, and body fat mass at baseline, end of intervention (Day 29), and follow-up (Day 119).</title></caption><alternatives><graphic id="pone-0047079-t005-5" xlink:href="pone.0047079.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Variable</td><td align="left" rowspan="1" colspan="1">Time</td><td align="left" rowspan="1" colspan="1">Control diet</td><td align="left" rowspan="1" colspan="1">CR diet</td><td align="left" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="nt112">a</xref>
</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Body Weight(kg)</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">86.9 (72.2&#x02013;96.2)</td><td align="left" rowspan="1" colspan="1">85.5 (70.4&#x02013;99.4)</td><td align="left" rowspan="1" colspan="1">0.740</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">86.9 (71.1&#x02013;97.6)</td><td align="left" rowspan="1" colspan="1">82.8 (68.5&#x02013;95.8)</td><td align="left" rowspan="1" colspan="1">0.504</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">87.8 (79.7&#x02013;98.7)</td><td align="left" rowspan="1" colspan="1">84.5 (72.6&#x02013;96.3)</td><td align="left" rowspan="1" colspan="1">0.491</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">30.1 (28.1&#x02013;38.3)</td><td align="left" rowspan="1" colspan="1">32.3 (26.6&#x02013;36.2)</td><td align="left" rowspan="1" colspan="1">0.538</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">30.1 (27.6&#x02013;38.8)</td><td align="left" rowspan="1" colspan="1">31.5 (25.7&#x02013;35.3)</td><td align="left" rowspan="1" colspan="1">0.438</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">30.0 (28.5&#x02013;39.0)</td><td align="left" rowspan="1" colspan="1">32.1 (26.2&#x02013;35.8)</td><td align="left" rowspan="1" colspan="1">0.329</td></tr><tr><td align="left" rowspan="1" colspan="1">Body Fat (kg)</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">39.3 (33.2&#x02013;44.1)</td><td align="left" rowspan="1" colspan="1">38.5 (27.4&#x02013;49.0)</td><td align="left" rowspan="1" colspan="1">0.946</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">39.9 (31.0&#x02013;44.0)</td><td align="left" rowspan="1" colspan="1">38.0 (26.0&#x02013;47.0)</td><td align="left" rowspan="1" colspan="1">0.598</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">39.1 (33.5&#x02013;45.9)</td><td align="left" rowspan="1" colspan="1">36.7 (27.8&#x02013;44.3)</td><td align="left" rowspan="1" colspan="1">0.544</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt110"><p>Data are presented as median (interquartile range - IQR).</p></fn><fn id="nt111"><p>Abbreviations: CR diet, caloric restriction diet; BMI, body mass index (kg/m<sup>2</sup>).</p></fn><fn id="nt112"><label>a</label><p>Wilcoxon rank sum test for differences between Control and CR diets.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0047079-t006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0047079.t006</object-id><label>Table 6</label><caption><title>Resting energy expenditure, physical activity-related energy expenditure and physical activity level (PAL) at baseline, end of intervention (Day 29), and day follow-up (Day 119).</title></caption><alternatives><graphic id="pone-0047079-t006-6" xlink:href="pone.0047079.t006"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Variable</td><td align="left" rowspan="1" colspan="1">Time</td><td align="left" rowspan="1" colspan="1">Control diet</td><td colspan="2" align="left" rowspan="1">CR diet</td><td align="left" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="nt115">a</xref>
</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">REE</td><td align="left" rowspan="1" colspan="1">Baseline</td><td colspan="2" align="left" rowspan="1">1.33 (1.22&#x02013;1.37)</td><td align="left" rowspan="1" colspan="1">1.22 (1.18&#x02013;1.37)</td><td align="left" rowspan="1" colspan="1">0.255</td></tr><tr><td align="left" rowspan="1" colspan="1">(kcal/min)</td><td align="left" rowspan="1" colspan="1">Day 29</td><td colspan="2" align="left" rowspan="1">1.33 (1.21&#x02013;1.38)</td><td align="left" rowspan="1" colspan="1">1.20 (1.17&#x02013;1.35)</td><td align="left" rowspan="1" colspan="1">0.191</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td colspan="2" align="left" rowspan="1">1.35 (1.27&#x02013;1.39)</td><td align="left" rowspan="1" colspan="1">1.28 (1.19&#x02013;1.40)</td><td align="left" rowspan="1" colspan="1">0.330</td></tr><tr><td align="left" rowspan="1" colspan="1">PAEE</td><td align="left" rowspan="1" colspan="1">Baseline</td><td colspan="2" align="left" rowspan="1">502.7 (471.7&#x02013;514.3)</td><td align="left" rowspan="1" colspan="1">519.5 (423.3&#x02013;542.5)</td><td align="left" rowspan="1" colspan="1">0.740</td></tr><tr><td align="left" rowspan="1" colspan="1">(kcal/day)</td><td align="left" rowspan="1" colspan="1">Day 29</td><td colspan="2" align="left" rowspan="1">554.0 (511.0&#x02013;648.1)</td><td align="left" rowspan="1" colspan="1">492.8 (463.1&#x02013;553.9)</td><td align="left" rowspan="1" colspan="1">0.057</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td colspan="2" align="left" rowspan="1">505.5 (476.8&#x02013;540.3)</td><td align="left" rowspan="1" colspan="1">497.8 (425.4&#x02013;514.5)</td><td align="left" rowspan="1" colspan="1">0.415</td></tr><tr><td align="left" rowspan="1" colspan="1">PAL</td><td align="left" rowspan="1" colspan="1">Baseline</td><td colspan="2" align="left" rowspan="1">1.31 (1.31&#x02013;1.32)</td><td align="left" rowspan="1" colspan="1">1.27 (1.25&#x02013;1.32)</td><td align="left" rowspan="1" colspan="1">0.078</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 29</td><td colspan="2" align="left" rowspan="1">1.33 (1.31&#x02013;1.33)</td><td align="left" rowspan="1" colspan="1">1.29 (1.25&#x02013;1.35)</td><td align="left" rowspan="1" colspan="1">0.303</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td colspan="2" align="left" rowspan="1">1.32 (1.31&#x02013;1.33)</td><td align="left" rowspan="1" colspan="1">1.27 (1.25&#x02013;1.31)</td><td align="left" rowspan="1" colspan="1">0.012</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt113"><p>Data are presented as median (interquartile range -IQR).</p></fn><fn id="nt114"><p>Abbreviations: REE, resting energy expenditure; PAEE, physical activity-related energy expenditure calculated as a difference between total and resting energy expenditure; PAL, physical activity level calculated as a ratio of total energy expenditure to REE, CR diet, caloric restriction diet.</p></fn><fn id="nt115"><label>a</label><p>Wilcoxon rank sum test for differences between Control and CR diets.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0047079-t007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0047079.t007</object-id><label>Table 7</label><caption><title>Median daily macro- and selected micro-nutrient intake in the caloric restriction (CR) and Control diet groups.</title></caption><alternatives><graphic id="pone-0047079-t007-7" xlink:href="pone.0047079.t007"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="4" align="left" rowspan="1">Control diet</td><td colspan="3" align="left" rowspan="1">CR diet</td></tr><tr><td align="left" rowspan="1" colspan="1">Nutrient</td><td align="left" rowspan="1" colspan="1">Median</td><td colspan="2" align="left" rowspan="1">IQR</td><td colspan="3" align="left" rowspan="1">Median</td><td align="left" rowspan="1" colspan="1">IQR</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Energy (kcal)</td><td align="left" rowspan="1" colspan="1">2062.4</td><td align="left" rowspan="1" colspan="1">(1906.1&#x02013;2119.9)</td><td colspan="3" align="left" rowspan="1">1543.3<xref ref-type="table-fn" rid="nt117">1</xref>
</td><td colspan="2" align="left" rowspan="1">(1410.9&#x02013;1784.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Fat (g)</td><td align="left" rowspan="1" colspan="1">54.7</td><td align="left" rowspan="1" colspan="1">(52.8&#x02013;67.6)</td><td colspan="3" align="left" rowspan="1">44.2<xref ref-type="table-fn" rid="nt117">1</xref>
</td><td colspan="2" align="left" rowspan="1">(33.5&#x02013;54.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Carbohydrate (g)</td><td align="left" rowspan="1" colspan="1">276.1</td><td align="left" rowspan="1" colspan="1">(253.5&#x02013;329.6)</td><td colspan="3" align="left" rowspan="1">227.9<xref ref-type="table-fn" rid="nt117">1</xref>
</td><td colspan="2" align="left" rowspan="1">(213.1&#x02013;253.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">Protein (g)</td><td align="left" rowspan="1" colspan="1">101.2</td><td align="left" rowspan="1" colspan="1">(93.3&#x02013;124.2)</td><td colspan="3" align="left" rowspan="1">82.0<xref ref-type="table-fn" rid="nt117">1</xref>
</td><td colspan="2" align="left" rowspan="1">(70.9&#x02013;93.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Glycemic Load (bread reference)</td><td align="left" rowspan="1" colspan="1">213.7</td><td align="left" rowspan="1" colspan="1">(197.3&#x02013;241.3)</td><td colspan="3" align="left" rowspan="1">162.1<xref ref-type="table-fn" rid="nt117">1</xref>
</td><td colspan="2" align="left" rowspan="1">(141.5&#x02013;183.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Dietary Fiber (g)</td><td align="left" rowspan="1" colspan="1">21.9</td><td align="left" rowspan="1" colspan="1">(18.8&#x02013;24.3)</td><td colspan="3" align="left" rowspan="1">24.4</td><td colspan="2" align="left" rowspan="1">(22.1&#x02013;27.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin A (retinol equivalents) (mcg)</td><td align="left" rowspan="1" colspan="1">1886.8</td><td align="left" rowspan="1" colspan="1">(1736.8&#x02013;2107.2)</td><td colspan="3" align="left" rowspan="1">2034.7</td><td colspan="2" align="left" rowspan="1">(2202.3&#x02013;6755.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin D (IU)</td><td align="left" rowspan="1" colspan="1">337.4</td><td align="left" rowspan="1" colspan="1">(293.4&#x02013;392.8)</td><td colspan="3" align="left" rowspan="1">325.2</td><td colspan="2" align="left" rowspan="1">(312.6&#x02013;355.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin E (IU)</td><td align="left" rowspan="1" colspan="1">8.5</td><td align="left" rowspan="1" colspan="1">(7.1&#x02013;12.0)</td><td colspan="3" align="left" rowspan="1">7.7</td><td colspan="2" align="left" rowspan="1">(6.4&#x02013;9.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin C (ascorbic acid) (mg)</td><td align="left" rowspan="1" colspan="1">87.0</td><td align="left" rowspan="1" colspan="1">(73.0&#x02013;116.3)</td><td colspan="3" align="left" rowspan="1">127.1</td><td colspan="2" align="left" rowspan="1">(100.9&#x02013;167.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin B<sub>1</sub> (thiamin) (mg)</td><td align="left" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1">(1.4&#x02013;1.7)</td><td colspan="3" align="left" rowspan="1">1.2</td><td colspan="2" align="left" rowspan="1">(1.0&#x02013;1.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin B<sub>2</sub> (riboflavin) (mg)</td><td align="left" rowspan="1" colspan="1">2.2</td><td align="left" rowspan="1" colspan="1">(2.1&#x02013;2.8)</td><td colspan="3" align="left" rowspan="1">1.9</td><td colspan="2" align="left" rowspan="1">(1.7&#x02013;2.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin B<sub>6</sub> (mg)(piridoxal, piridoxamine, piridoxin)</td><td align="left" rowspan="1" colspan="1">2.0</td><td align="left" rowspan="1" colspan="1">(1.8&#x02013;2.1)</td><td colspan="3" align="left" rowspan="1">1.5</td><td colspan="2" align="left" rowspan="1">(1.3&#x02013;1.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Niacin (mg)</td><td align="left" rowspan="1" colspan="1">22.5</td><td align="left" rowspan="1" colspan="1">(20.9&#x02013;24.9)</td><td colspan="3" align="left" rowspan="1">19.4</td><td colspan="2" align="left" rowspan="1">(15.0&#x02013;22.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Folate (mcg)</td><td align="left" rowspan="1" colspan="1">574.3</td><td align="left" rowspan="1" colspan="1">(524.8&#x02013;685.5)</td><td colspan="3" align="left" rowspan="1">501.7</td><td colspan="2" align="left" rowspan="1">(464.5&#x02013;552.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin B<sub>12</sub> (cobalamin) (mcg)</td><td align="left" rowspan="1" colspan="1">6.9</td><td align="left" rowspan="1" colspan="1">(5.7&#x02013;7.6)</td><td colspan="3" align="left" rowspan="1">4.6</td><td colspan="2" align="left" rowspan="1">(3.4&#x02013;6.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Sodium (mg)</td><td align="left" rowspan="1" colspan="1">3588.8</td><td align="left" rowspan="1" colspan="1">(3319.3&#x02013;4209.7)</td><td colspan="3" align="left" rowspan="1">2604.4</td><td colspan="2" align="left" rowspan="1">(2112.0&#x02013;3433.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Calcium (mg)</td><td align="left" rowspan="1" colspan="1">822.3</td><td align="left" rowspan="1" colspan="1">(729.1&#x02013;920.5)</td><td colspan="3" align="left" rowspan="1">1008.6</td><td colspan="2" align="left" rowspan="1">(881.6&#x02013;1147.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Magnesium (mg)</td><td align="left" rowspan="1" colspan="1">509.2</td><td align="left" rowspan="1" colspan="1">(451.7&#x02013;540.7)</td><td colspan="3" align="left" rowspan="1">455.3</td><td colspan="2" align="left" rowspan="1">(436.8&#x02013;482.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Iron (mg)</td><td align="left" rowspan="1" colspan="1">14.4</td><td align="left" rowspan="1" colspan="1">(12.1&#x02013;15.2)</td><td colspan="3" align="left" rowspan="1">9.4</td><td colspan="2" align="left" rowspan="1">(7.7&#x02013;11.5)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt116"><p>Data are presented as median (interquartile range -IQR).</p></fn><fn id="nt117"><label>1</label><p>- different from Control diet, p&#x0003c;0.001, Wilcoxon rank sum test.</p></fn><fn id="nt118"><p>Daily multivitamin supplement was given during intervention Days 1&#x02013;28 (Multi Complete, Nature Made, Mission Hills, CA) composition: vitamin A - 2 500 IU, vitamin D<sub>3</sub> - 1000 IU, vitamin E - 50 IU, vitamin C - 180 mg, vitamin B<sub>1</sub> - 15 mg, vitamin B<sub>2</sub> - 1.7 mg, niacin - 20 mg, vitamin B<sub>6</sub> - 2 mg, folate - 400 mcg, vitamin B<sub>12</sub> - 6 mcg, calcium 162 mg, magnesium - 100 mg, iron - 18 mg, selenium - 70 mcg.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3d"><title>Changes in other Disease Associated Markers</title><p>The CR diet did not have a significant effect on either systolic or diastolic blood pressure or serum concentrations of insulin, leptin, adiponectin, total cholesterol, LDL cholesterol, HDL cholesterol, CRP and triglycerides (<xref ref-type="table" rid="pone-0047079-t008">Tables 8</xref> and <xref ref-type="table" rid="pone-0047079-t009">9</xref>).</p><table-wrap id="pone-0047079-t008" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0047079.t008</object-id><label>Table 8</label><caption><title>Blood pressure, hormones, and lipids at baseline, end of intervention (Day 29), and follow-up (Day 119).</title></caption><alternatives><graphic id="pone-0047079-t008-8" xlink:href="pone.0047079.t008"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Variable</td><td align="left" rowspan="1" colspan="1">Time</td><td align="left" rowspan="1" colspan="1">Control diet</td><td align="left" rowspan="1" colspan="1">CR diet</td><td align="left" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="nt121">1</xref>
</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Systolic blood</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">121.5 (120.1&#x02013;126.5)</td><td align="left" rowspan="1" colspan="1">128.5 (122.8&#x02013;132.3)</td><td align="left" rowspan="1" colspan="1">0.052</td></tr><tr><td align="left" rowspan="1" colspan="1">pressure (mmHg)</td><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">125.0 (123.0&#x02013;126.0)</td><td align="left" rowspan="1" colspan="1">123.0 (117.3&#x02013;129.0)</td><td align="left" rowspan="1" colspan="1">0.648</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">126.0 (124.5&#x02013;128.0)</td><td align="left" rowspan="1" colspan="1">125.0 (121.5&#x02013;131.5)</td><td align="left" rowspan="1" colspan="1">0.897</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic blood</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">79.5 (76.5&#x02013;82.5)</td><td align="left" rowspan="1" colspan="1">77.5 (74.0&#x02013;82.0)</td><td align="left" rowspan="1" colspan="1">0.206</td></tr><tr><td align="left" rowspan="1" colspan="1">pressure (mmHg)</td><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">79.0 (78.0&#x02013;81.5)</td><td align="left" rowspan="1" colspan="1">77.0 (73.0&#x02013;81.0)</td><td align="left" rowspan="1" colspan="1">0.116</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">77.0 (75.0&#x02013;80.0)</td><td align="left" rowspan="1" colspan="1">77.0 (75.0&#x02013;79.8)</td><td align="left" rowspan="1" colspan="1">0.983</td></tr><tr><td align="left" rowspan="1" colspan="1">Insulin (uU/mL)</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">13.8 (7.0&#x02013;16.8)</td><td align="left" rowspan="1" colspan="1">11.7 (8.9&#x02013;17.0)</td><td align="left" rowspan="1" colspan="1">0.803</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">11.1 (8.1&#x02013;17.0)</td><td align="left" rowspan="1" colspan="1">9.8 (6.8&#x02013;12.6)</td><td align="left" rowspan="1" colspan="1">0.514</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">11.5 (7.5&#x02013;16.1)</td><td align="left" rowspan="1" colspan="1">10.1 (8.9&#x02013;15.2)</td><td align="left" rowspan="1" colspan="1">0.830</td></tr><tr><td align="left" rowspan="1" colspan="1">Leptin (ng/mL)</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">19.5 (16.5&#x02013;25.6)</td><td align="left" rowspan="1" colspan="1">21.1 (15.4&#x02013;28.0)</td><td align="left" rowspan="1" colspan="1">0.974</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">19.6 (16.4&#x02013;31.1)</td><td align="left" rowspan="1" colspan="1">17.8 (11.6&#x02013;24.2)</td><td align="left" rowspan="1" colspan="1">0.250</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">17.8 (15.9&#x02013;25.9)</td><td align="left" rowspan="1" colspan="1">22.6 (15.4&#x02013;26.8)</td><td align="left" rowspan="1" colspan="1">0.784</td></tr><tr><td align="left" rowspan="1" colspan="1">Adiponectin</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">9.1 (5.5&#x02013;10.2)</td><td align="left" rowspan="1" colspan="1">10.0 (7.7&#x02013;13.8)</td><td align="left" rowspan="1" colspan="1">0.235</td></tr><tr><td align="left" rowspan="1" colspan="1">(ng/mL)</td><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">7.2 (5.9&#x02013;11.3)</td><td align="left" rowspan="1" colspan="1">12.0 (7.8&#x02013;15.7)</td><td align="left" rowspan="1" colspan="1">0.114</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">8.1 (7.0&#x02013;9.9)</td><td align="left" rowspan="1" colspan="1">12.1 (8.7&#x02013;17.7)</td><td align="left" rowspan="1" colspan="1">0.243</td></tr><tr><td align="left" rowspan="1" colspan="1">Triglyceride</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">134.5 (131.5&#x02013;154.0)</td><td align="left" rowspan="1" colspan="1">138.0 (122.0&#x02013;153.2)</td><td align="left" rowspan="1" colspan="1">0.595</td></tr><tr><td align="left" rowspan="1" colspan="1">(mg/dL)</td><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">142.0 (131.0&#x02013;157.0)</td><td align="left" rowspan="1" colspan="1">132.0 (118.0&#x02013;144.0)</td><td align="left" rowspan="1" colspan="1">0.125</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">126.0 (124.5&#x02013;149.0)</td><td align="left" rowspan="1" colspan="1">135.0 (121.5&#x02013;145.0)</td><td align="left" rowspan="1" colspan="1">0.587</td></tr><tr><td align="left" rowspan="1" colspan="1">Totalcholesterol</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">214.5 (189.5&#x02013;241.2)</td><td align="left" rowspan="1" colspan="1">208.0 (181.0&#x02013;226.2)</td><td align="left" rowspan="1" colspan="1">0.454</td></tr><tr><td align="left" rowspan="1" colspan="1">(mg/dL)</td><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">214.5 (188.8&#x02013;227.8)</td><td align="left" rowspan="1" colspan="1">190.5 (174.2&#x02013;210.8)</td><td align="left" rowspan="1" colspan="1">0.378</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">215.0 (205.0&#x02013;231.5)</td><td align="left" rowspan="1" colspan="1">209.0 (186.0&#x02013;220.0)</td><td align="left" rowspan="1" colspan="1">0.391</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL (mg/dL)</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">148.8 (110.0&#x02013;167.8)</td><td align="left" rowspan="1" colspan="1">132.0 (105.8&#x02013;150.2)</td><td align="left" rowspan="1" colspan="1">0.377</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">152.0 (122.2&#x02013;159.2)</td><td align="left" rowspan="1" colspan="1">118.5 (107.2&#x02013;143.8)</td><td align="left" rowspan="1" colspan="1">0.208</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">149.0 (137.5&#x02013;153.5)</td><td align="left" rowspan="1" colspan="1">125.0 (117.0&#x02013;142.5)</td><td align="left" rowspan="1" colspan="1">0.132</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL(mg/dL)</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">45.5 (36.0&#x02013;53.5)</td><td align="left" rowspan="1" colspan="1">46.0 (42.0&#x02013;54.2)</td><td align="left" rowspan="1" colspan="1">0.752</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">42.0 (35.0&#x02013;46.0)</td><td align="left" rowspan="1" colspan="1">44.0 (35.0&#x02013;54.0)</td><td align="left" rowspan="1" colspan="1">0.515</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">48.0 (40.5&#x02013;50.5)</td><td align="left" rowspan="1" colspan="1">46.0 (41.0&#x02013;52.0)</td><td align="left" rowspan="1" colspan="1">0.573</td></tr><tr><td align="left" rowspan="1" colspan="1">Free fatty acids</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">0.41 (0.32&#x02013;0.60)</td><td align="left" rowspan="1" colspan="1">0.53 (0.37&#x02013;0.73)</td><td align="left" rowspan="1" colspan="1">0.262</td></tr><tr><td align="left" rowspan="1" colspan="1">(mmol/L)</td><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">0.41 (0.31&#x02013;0.53)</td><td align="left" rowspan="1" colspan="1">0.52 (0.42&#x02013;0.67)</td><td align="left" rowspan="1" colspan="1">0.108</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">0.38 (0.35&#x02013;0.55)</td><td align="left" rowspan="1" colspan="1">0.49 (0.40&#x02013;0.65)</td><td align="left" rowspan="1" colspan="1">0.156</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt119"><p>Data are presented as median (interquartile range -IQR).</p></fn><fn id="nt120"><p>Abbreviations: LDL, low-density lipoprotein; HDL, high-density lipoprotein.</p></fn><fn id="nt121"><label>1</label><p>Wilcoxon rank sum test for differences between Control and CR diets.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0047079-t009" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0047079.t009</object-id><label>Table 9</label><caption><title>Inflammatory markers at baseline, end of intervention (Day 29), and follow-up (Day 119).</title></caption><alternatives><graphic id="pone-0047079-t009-9" xlink:href="pone.0047079.t009"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Variable</td><td align="left" rowspan="1" colspan="1">Time</td><td align="left" rowspan="1" colspan="1">Control diet</td><td align="left" rowspan="1" colspan="1">CR diet</td><td align="left" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="nt123">1</xref>
</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Tumor necrosis</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">5.67 (1.65&#x02013;9.25)</td><td align="left" rowspan="1" colspan="1">2.88 (0.00&#x02013;5.22)</td><td align="left" rowspan="1" colspan="1">0.310</td></tr><tr><td align="left" rowspan="1" colspan="1">factor -&#x000e1; (ug/dL)</td><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">5.90 (1.40&#x02013;9.11)</td><td align="left" rowspan="1" colspan="1">3.08 (0.00&#x02013;8.00)</td><td align="left" rowspan="1" colspan="1">0.555</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">7.67 (2.48&#x02013;8.81)</td><td align="left" rowspan="1" colspan="1">4.96 (0.00&#x02013;5.68)</td><td align="left" rowspan="1" colspan="1">0.340</td></tr><tr><td align="left" rowspan="1" colspan="1">Interleukin -12</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">6.47 (5.30&#x02013;9.52)</td><td align="left" rowspan="1" colspan="1">2.75 (0.00&#x02013;5.68)</td><td align="left" rowspan="1" colspan="1">0.027</td></tr><tr><td align="left" rowspan="1" colspan="1">(pg/mL)</td><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">9.53 (5.70&#x02013;10.39)</td><td align="left" rowspan="1" colspan="1">3.19 (0.00&#x02013;5.81)</td><td align="left" rowspan="1" colspan="1">0.027</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">8.33 (7.48&#x02013;9.39)</td><td align="left" rowspan="1" colspan="1">4.26 (0.00&#x02013;6.94)</td><td align="left" rowspan="1" colspan="1">0.007</td></tr><tr><td align="left" rowspan="1" colspan="1">Interleukin -8</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">8.55 (8.20&#x02013;17.73)</td><td align="left" rowspan="1" colspan="1">5.02 (3.04&#x02013;8.37)</td><td align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">(pg/mL)</td><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">9.72 (7.32&#x02013;39.30)</td><td align="left" rowspan="1" colspan="1">6.48 (4.87&#x02013;8.29)</td><td align="left" rowspan="1" colspan="1">0.019</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">7.41 (7.16&#x02013;25.88)</td><td align="left" rowspan="1" colspan="1">5.94 (2.65&#x02013;8.55)</td><td align="left" rowspan="1" colspan="1">0.075</td></tr><tr><td align="left" rowspan="1" colspan="1">C-reactiveprotein</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">6.00 (3.00&#x02013;9.50)</td><td align="left" rowspan="1" colspan="1">3.50 (1.00&#x02013;6.00)</td><td align="left" rowspan="1" colspan="1">0.157</td></tr><tr><td align="left" rowspan="1" colspan="1">(ug/mL)</td><td align="left" rowspan="1" colspan="1">Day 29</td><td align="left" rowspan="1" colspan="1">4.20 (2.65&#x02013;7.25)</td><td align="left" rowspan="1" colspan="1">2.60 (1.00&#x02013;6.25)</td><td align="left" rowspan="1" colspan="1">0.274</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Day 119</td><td align="left" rowspan="1" colspan="1">4.70 (1.12&#x02013;9.10)</td><td align="left" rowspan="1" colspan="1">3.00 (1.00&#x02013;5.07)</td><td align="left" rowspan="1" colspan="1">0.776</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt122"><p>Data are presented as median (interquartile range - IQR). CR, caloric restriction diet.</p></fn><fn id="nt123"><label>1</label><p>Wilcoxon rank sum test for differences between Control and CR diets.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s4"><title>Discussion</title><p>The novelty of the present study is that we investigated serial changes in a marker of oxidative stress induced by 28-days of a caloric restriction diet. The main finding is that moderate (25%) CR and modest weight loss causes a rapid decrease in oxidative stress as measured by plasma F<sub>2</sub>-isoprostane concentrations, to within the normal range exhibited by non-obese adults (35&#x000b1;6 pg/ml). The magnitude of this change was significant in comparison to baseline F<sub>2</sub>-isoprostane plasma concentrations. This suggests that the potential benefits from reducing the oxidative stress level can be achieved rapidly without restricting caloric intake to a level that overweight and obese people might find difficult to sustain.</p><p>CR is hypothesized to lessen oxidative damage by reducing energy flux and metabolism with a consequential lowering of reactive oxygen species and rate of oxidative damage to vital tissues <xref rid="pone.0047079-Sohal1" ref-type="bibr">[36]</xref>. Several studies documented the association of CR with lowering of resting metabolic rate and thermic effect of food, and a decrease in cost of physical activity <xref rid="pone.0047079-Redman1" ref-type="bibr">[37]</xref>. For example, Heilbronn et al <xref rid="pone.0047079-Heilbronn1" ref-type="bibr">[38]</xref> showed 6 months of caloric restriction (25%) significantly decreased sedentary 24-hour energy expenditure after adjusting for body composition. In the present study, we did not observe significant reductions in adjusted energy expenditure most likely because of a much shorter intervention period (1 month vs. 6 months). Other reported benefits of long-term CR, but not detected in our study, include reduction in fasting glucose and insulin, which are linked to decreased insulin resistance and risk for type 2 diabetes <xref rid="pone.0047079-Yagi1" ref-type="bibr">[39]</xref>.</p><p>Our results showing decreased F<sub>2</sub>-isoprostane with weight loss are consistent with a previous Davi et al <xref rid="pone.0047079-Davi1" ref-type="bibr">[40]</xref> study involving 11 obese women who participated in a diet-induced weight loss program for a 12-week period and lost at least 5 kg of initial body weight. In eight of these women, there was a significant reduction in urinary excretion of F<sub>2</sub>-isoprostane. In a recent study on the effect of CR and glycemic load on oxidative stress, Meydani et al <xref rid="pone.0047079-Meydani1" ref-type="bibr">[17]</xref> showed non-significant decreases in plasma 8-epi-prostaglandin F<sub>2&#x000e1;</sub> (P&#x0200a;=&#x0200a;0.09) and protein carbonyl (P&#x0200a;=&#x0200a;0.02), and a significant increases in plasma glutathione peroxidase activity (P&#x0200a;=&#x0200a;0.04). In contrast, a randomized controlled trial with 42 participants with the metabolic syndrome assigned to 16 weeks of weight maintenance or a 12-week weight-loss program followed by 4 weeks of weight stabilization, showed different results. Relative to the weight-maintenance group, a 4-kg loss in weight resulted in a significant decrease in blood pressure but did not alter urinary or plasma F<sub>2</sub>-isoprostane <xref rid="pone.0047079-Tsai1" ref-type="bibr">[41]</xref>. The discrepancies between these studies could be explained, at least in part, by different methodology (plasma or urinary isoprostanes), various experimental designs, and diverse study populations.</p><p>Baseline F<sub>2</sub>-isoprostane correlated with body fat content. However, the F<sub>2</sub>-isoprostane decrease during the CR intervention was not correlated with the concurrent changes in body fat. Although we used a clinical trial design, strict diet control, and validated biomarkers <xref rid="pone.0047079-Roberts1" ref-type="bibr">[42]</xref>, <xref rid="pone.0047079-Ridker1" ref-type="bibr">[43]</xref>, it was not possible to determine whether body fat itself was a source of oxidative stress. As far as we are aware, F<sub>2</sub>-isoprostanes, although present in foods, are not absorbed through the gut <xref rid="pone.0047079-Richelle1" ref-type="bibr">[44]</xref>, <xref rid="pone.0047079-Gopaul1" ref-type="bibr">[45]</xref>. A plausible explanation is that in addition to a decrease in energy content, changes in content and amount of macronutrients consumed affected systemic oxidative balance. Lower concentrations of protein, carbohydrates, and lipids in the CR diet, when compared to habitual diets reported by Control diet participants, could have potentially shifted postprandial oxidative status towards decreased susceptibility to oxidative damage <xref rid="pone.0047079-CodoerFranch1" ref-type="bibr">[46]</xref>. Indeed, previous research has shown that postprandial increases of lipid and carbohydrate concentrations lead to increased oxidative stress <xref rid="pone.0047079-TsaiWC1" ref-type="bibr">[47]</xref> and consequent hyperlipidemia and hyperglycemia <xref rid="pone.0047079-Bae1" ref-type="bibr">[48]</xref>.</p><p>Although our study did not test whether decreases in oxidative stress are linked to an improvement in risk factors for associated chronic diseases, previous data do provide such evidence. Zacardi et al <xref rid="pone.0047079-Ziccardi1" ref-type="bibr">[49]</xref> reported that declines in adhesion molecules and improvement in endothelial function with sustained weight loss were related to decreases in IL-6 and TNF-&#x003b1;, independent of change in adiposity and body fat distribution. Despite the many studies that have examined the role of oxidative stress on cardiovascular health, mechanistic studies designed to abruptly reduce plasma oxidative stress and to subsequently determine the acute effects of this intervention on antioxidative capacity, oxidative stress, and vascular function have not been extensively reported. For example, studies in young and older individuals demonstrated a dichotomous effect of antioxidant consumption on endothelial function with age <xref rid="pone.0047079-Wray1" ref-type="bibr">[50]</xref>. Nevertheless, if the link between obesity and increased oxidative stress is confirmed, the potential for antioxidant therapy to decrease the risk of obesity-related co-morbid conditions such as cardiovascular disease warrants additional studies in diverse populations <xref rid="pone.0047079-Higdon1" ref-type="bibr">[51]</xref>.</p><p>Our findings extend those of previous studies in several ways. First, our data provide evidence from a controlled trial design that the decrease in oxidative stress biomarkers induced by a modest caloric restriction is rapid. This is important because obese individuals are unable to consistently comply with a long-term daily caloric reduction of 40% (consuming 60% of maintenance), as has been used in most animals studies <xref rid="pone.0047079-Heilbronn2" ref-type="bibr">[52]</xref>. Second, the study causally links the measured decreases in F<sub>2</sub>-isoprostane to the weight loss induced by caloric restriction. Third, we demonstrated that return to a habitual diet, with consequent gradual regaining of weight, causes an increase of F<sub>2</sub>-isoprostane to pre-study, elevated baseline levels. This observation may have clinical significance especially in weight cycling (yo-yo dieting) <xref rid="pone.0047079-Hall1" ref-type="bibr">[53]</xref>, <xref rid="pone.0047079-Strychar1" ref-type="bibr">[54]</xref> and weight-loss maintenance <xref rid="pone.0047079-Pieper1" ref-type="bibr">[55]</xref>. It has been reported that weight cycling is a relatively common phenomenon in women, ranging from 19% in White <xref rid="pone.0047079-Field1" ref-type="bibr">[56]</xref>, <xref rid="pone.0047079-LahtiKoski1" ref-type="bibr">[57]</xref> to 63% in African American women <xref rid="pone.0047079-Osborn1" ref-type="bibr">[58]</xref>, as well as in approximately 10% of men <xref rid="pone.0047079-LahtiKoski1" ref-type="bibr">[57]</xref>. Weight cycling has a negative impact on body composition and body fat distribution <xref rid="pone.0047079-Cereda1" ref-type="bibr">[59]</xref>, <xref rid="pone.0047079-Dulloo1" ref-type="bibr">[60]</xref>, and has been associated with an increased risk for metabolic syndrome <xref rid="pone.0047079-Hooper1" ref-type="bibr">[61]</xref>,cardiovascular disease <xref rid="pone.0047079-Graci1" ref-type="bibr">[62]</xref>, and all-cause mortality <xref rid="pone.0047079-Stevens1" ref-type="bibr">[63]</xref>. Now we have a clear understanding of how weight cycling stimulates adjustments in energy homeostatic hormones (leptin, ghrelin, and insulin) that activate regulatory mechanisms to restore weight <xref rid="pone.0047079-Hooper2" ref-type="bibr">[64]</xref>.</p><p>However, we do not know whether energy intake-induced weight cycling is affecting oxidative stress level. Our results support the notions that during caloric restriction and subsequent weight loss, oxidative stress level decreases, and in contrast, increases during a positive caloric balance and subsequent weight gain. Thus, we hypothesize that previously mentioned health consequences of weight cycling such as increased risk for metabolic syndrome and cardiovascular disease could be associated, at least in part, with changes in the oxidative stress level. Future clinical studies are necessary to explain whether these associations can be attenuated by frequent weight cycling and what mechanisms (e.g. lipids oxidation, insulin resistance, and inflammation) are involved.</p><p>A limitation of the present study is the relatively small number of participants; hence, the results need to be confirmed in larger studies. In addition, individuals in the control group ate their habitual diets, thus it was possible that their intake of antioxidants (e.g., vitamin E,) and other micronutrient would be below the recommended allowances. To prevent this possibility, participants in both groups received a vitamin/mineral supplement daily. As a result, vitamin E intake was similar in the control and CR groups (&#x0223c;58 international units), which was in line with the daily recommended intake of 22.4 to 50 international units for younger and older adults, respectively <xref rid="pone.0047079-Institute1" ref-type="bibr">[65]</xref>.</p><p>Although the use of F<sub>2</sub>-isoprostanes as a marker of oxidative stress is a strength <xref rid="pone.0047079-Heilbronn3" ref-type="bibr">[66]</xref>, the study would have greatly benefited from measurement of water-soluble oxidation markers such as thiobarbituric acid reactive substances <xref rid="pone.0047079-Yagi1" ref-type="bibr">[39]</xref> and total antioxidant capacity <xref rid="pone.0047079-Davalos1" ref-type="bibr">[67]</xref>, <xref rid="pone.0047079-Apak1" ref-type="bibr">[68]</xref>. However, in the study on effect of diet-induced reduction in oxidative stress it has been showed that F<sub>2</sub>-isoprostane level was well correlated with advanced oxidation protein products <xref rid="pone.0047079-Nemzer1" ref-type="bibr">[69]</xref>. In addition, one should be cautious if generalizing this study&#x02019;s finding to males, obese individuals, and populations with serious obesity-related diseases, such as type 2 diabetes or hyperlipidemias. Further studies will be required to determine whether caloric restriction and weight loss lead to a reduction in F<sub>2</sub>-isoprostane and other markers of oxidative stress in such conditions. Finally, we did not explore the effect of age on our results. For example, it has been shown that antioxidant consumption acutely restores endothelial function in the elderly while disrupting normal endothelium-dependent vasodilation in the young, and suggest that this age-related impairment is attributed, at least in part, to free radicals <xref rid="pone.0047079-Wray2" ref-type="bibr">[70]</xref>. However, participants in our study were relatively healthy premenopausal women eliminating, at least in part, the potential effect of age on the results.</p><p>In summary, the results of the present study show that oxidative stress can be rapidly reduced and sustained through a modest (25%) reduction in caloric intake for a relatively short (28-day) period. Simultaneous reduction in markers of inflammation was associated with decreases in body fat and body weight. These changes suggest potential health benefits of modest caloric restriction in overweight and obese women.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0047079.s001"><label>Checklist S1</label><caption><p>
<bold>CONSORT Checklist.</bold>
</p><p>(DOC)</p></caption><media xlink:href="pone.0047079.s001.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0047079.s002"><label>Protocol S1</label><caption><p>
<bold>Trial Protocol.</bold>
</p><p>(DOCX)</p></caption><media xlink:href="pone.0047079.s002.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ref-list><title>References</title><ref id="pone.0047079-Vincent1"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Vincent</surname><given-names>HK</given-names></name>, <name><surname>Innes</surname><given-names>KE</given-names></name>, <name><surname>Vincent</surname><given-names>KR</given-names></name> (<year>2007</year>) <article-title>Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity</article-title>. <source>Diabetes, Obesity and Metabolism</source>
<volume>9</volume>: <fpage>813</fpage>&#x02013;<lpage>839</lpage>.</mixed-citation></ref><ref id="pone.0047079-Lumeng1"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Lumeng</surname><given-names>CN</given-names></name>, <name><surname>Saltiel</surname><given-names>AR</given-names></name> (<year>2011</year>) <article-title>Inflammatory links between obesity and metabolic disease</article-title>. <source>The Journal of Clinical Investigation</source>
<volume>121</volume>: <fpage>2111</fpage>&#x02013;<lpage>2117</lpage>.<pub-id pub-id-type="pmid">21633179</pub-id></mixed-citation></ref><ref id="pone.0047079-Hotamisligil1"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Hotamisligil</surname><given-names>GS</given-names></name> (<year>2006</year>) <article-title>Inflammation and metabolic disorders</article-title>. <source>Nature</source>
<volume>444</volume>: <fpage>860</fpage>&#x02013;<lpage>867</lpage>.<pub-id pub-id-type="pmid">17167474</pub-id></mixed-citation></ref><ref id="pone.0047079-Basu1"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Basu</surname><given-names>S</given-names></name> (<year>2008</year>) <article-title>F2-Isoprostanes in Human Health and Diseases: From Molecular Mechanisms to Clinical Implications</article-title>. <source>Antioxidants &#x00026; Redox Signaling</source>
<volume>10</volume>: <fpage>1405</fpage>&#x02013;<lpage>1434</lpage>.<pub-id pub-id-type="pmid">18522490</pub-id></mixed-citation></ref><ref id="pone.0047079-Furukawa1"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Furukawa</surname><given-names>S</given-names></name>, <name><surname>Fujita</surname><given-names>T</given-names></name>, <name><surname>Shimabukuro</surname><given-names>M</given-names></name>, <name><surname>Iwaki</surname><given-names>M</given-names></name>, <name><surname>Yamada</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Increased oxidative stress in obesity and its impact on metabolic syndrome</article-title>. <source>The Journal of Clinical Investigation</source>
<volume>114</volume>: <fpage>1752</fpage>&#x02013;<lpage>1761</lpage>.<pub-id pub-id-type="pmid">15599400</pub-id></mixed-citation></ref><ref id="pone.0047079-Tinahones1"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Tinahones</surname><given-names>FJ</given-names></name>, <name><surname>Murri-Pierri</surname><given-names>M</given-names></name>, <name><surname>Garrido-Sanchez</surname><given-names>L</given-names></name>, <name><surname>Garcia-Almeida</surname><given-names>JM</given-names></name>, <name><surname>Garcia-Serrano</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Oxidative Stress in Severely Obese Persons Is Greater in Those With Insulin Resistance</article-title>. <source>Obesity</source>
<volume>17</volume>: <fpage>240</fpage>&#x02013;<lpage>246</lpage>.<pub-id pub-id-type="pmid">19023278</pub-id></mixed-citation></ref><ref id="pone.0047079-Ouchi1"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Ouchi</surname><given-names>N</given-names></name>, <name><surname>Parker</surname><given-names>JL</given-names></name>, <name><surname>Lugus</surname><given-names>JJ</given-names></name>, <name><surname>Walsh</surname><given-names>K</given-names></name> (<year>2011</year>) <article-title>Adipokines in inflammation and metabolic disease</article-title>. <source>Nat Rev Immunol</source>
<volume>11</volume>: <fpage>85</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="pmid">21252989</pub-id></mixed-citation></ref><ref id="pone.0047079-Keaney1"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Keaney</surname><given-names>JF</given-names><suffix>Jr</suffix></name>, <name><surname>Larson</surname><given-names>MG</given-names></name>, <name><surname>Vasan</surname><given-names>RS</given-names></name>, <name><surname>Wilson</surname><given-names>PWF</given-names></name>, <name><surname>Lipinska</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study</article-title>. <source>Arterioscler Thromb Vasc Biol</source>
<volume>23</volume>: <fpage>434</fpage>&#x02013;<lpage>439</lpage>.<pub-id pub-id-type="pmid">12615693</pub-id></mixed-citation></ref><ref id="pone.0047079-Sawyer1"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Sawyer</surname><given-names>DB</given-names></name> (<year>2011</year>) <article-title>Oxidative Stress in Heart Failure: What Are We Missing</article-title>? <source>The American Journal of the Medical Sciences</source>
<volume>342</volume>: <fpage>120</fpage>&#x02013;<lpage>124</lpage> doi: 110.1097/MAJ.1090b1013e3182249fcd.<pub-id pub-id-type="pmid">21747279</pub-id></mixed-citation></ref><ref id="pone.0047079-Barocas1"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Barocas</surname><given-names>DA</given-names></name>, <name><surname>Motley</surname><given-names>S</given-names></name>, <name><surname>Cookson</surname><given-names>MS</given-names></name>, <name><surname>Chang</surname><given-names>SS</given-names></name>, <name><surname>Penson</surname><given-names>DF</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Oxidative Stress Measured by Urine F2-Isoprostane Level is Associated With Prostate Cancer</article-title>. <source>The Journal of Urology</source>
<volume>185</volume>: <fpage>2102</fpage>&#x02013;<lpage>2107</lpage>.<pub-id pub-id-type="pmid">21496850</pub-id></mixed-citation></ref><ref id="pone.0047079-DeMarzo1"><label>11</label><mixed-citation publication-type="journal">
<name><surname>De Marzo</surname><given-names>AM</given-names></name>, <name><surname>Platz</surname><given-names>EA</given-names></name>, <name><surname>Sutcliffe</surname><given-names>S</given-names></name>, <name><surname>Xu</surname><given-names>J</given-names></name>, <name><surname>Gronberg</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Inflammation in prostate carcinogenesis</article-title>. <source>Nat Rev Cancer</source>
<volume>7</volume>: <fpage>256</fpage>&#x02013;<lpage>269</lpage>.<pub-id pub-id-type="pmid">17384581</pub-id></mixed-citation></ref><ref id="pone.0047079-Couillard1"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Couillard</surname><given-names>C</given-names></name>, <name><surname>Ruel</surname><given-names>G</given-names></name>, <name><surname>Archer</surname><given-names>WR</given-names></name>, <name><surname>Pomerleau</surname><given-names>S</given-names></name>, <name><surname>Bergeron</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity</article-title>. <source>Journal of Clinical Endocrinology &#x00026; Metabolism</source>
<volume>90</volume>: <fpage>6454</fpage>&#x02013;<lpage>6459</lpage>.<pub-id pub-id-type="pmid">16189262</pub-id></mixed-citation></ref><ref id="pone.0047079-Helmersson1"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Helmersson</surname><given-names>J</given-names></name>, <name><surname>Vessby</surname><given-names>B</given-names></name>, <name><surname>Larsson</surname><given-names>A</given-names></name>, <name><surname>Basu</surname><given-names>S</given-names></name> (<year>2004</year>) <article-title>Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population</article-title>. <source>Circulation</source>
<volume>109</volume>: <fpage>1729</fpage>&#x02013;<lpage>1734</lpage>.<pub-id pub-id-type="pmid">15037525</pub-id></mixed-citation></ref><ref id="pone.0047079-Tchernof1"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Tchernof</surname><given-names>A</given-names></name>, <name><surname>Nolan</surname><given-names>A</given-names></name>, <name><surname>Sites</surname><given-names>CK</given-names></name>, <name><surname>Ades</surname><given-names>PA</given-names></name>, <name><surname>Poehlman</surname><given-names>ET</given-names></name> (<year>2002</year>) <article-title>Weight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Women</article-title>. <source>Circulation</source>
<volume>105</volume>: <fpage>564</fpage>&#x02013;<lpage>569</lpage>.<pub-id pub-id-type="pmid">11827920</pub-id></mixed-citation></ref><ref id="pone.0047079-Klimcakova1"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Klimcakova</surname><given-names>E</given-names></name>, <name><surname>Kovacikova</surname><given-names>M</given-names></name>, <name><surname>Stich</surname><given-names>V</given-names></name>, <name><surname>Langin</surname><given-names>D</given-names></name> (<year>2010</year>) <article-title>Adipokines and dietary interventions in human obesity</article-title>. <source>Obesity Reviews</source>
<volume>11</volume>: <fpage>446</fpage>&#x02013;<lpage>456</lpage>.<pub-id pub-id-type="pmid">20059706</pub-id></mixed-citation></ref><ref id="pone.0047079-Rolland1"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Rolland</surname><given-names>C</given-names></name>, <name><surname>Hession</surname><given-names>M</given-names></name> (<year>2011</year>) <collab>Broom</collab> (<year>2011</year>) <article-title>Effect of weight loss on adipokine levels in obese patients</article-title>. <source>Diabetes Metab Syndr Obes</source>
<volume>4</volume>: <fpage>315</fpage>&#x02013;<lpage>323</lpage>.<pub-id pub-id-type="pmid">21887104</pub-id></mixed-citation></ref><ref id="pone.0047079-Meydani1"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Meydani</surname><given-names>M</given-names></name>, <name><surname>Das</surname><given-names>S</given-names></name>, <name><surname>Band</surname><given-names>M</given-names></name>, <name><surname>Epstein</surname><given-names>S</given-names></name>, <name><surname>Roberts</surname><given-names>S</given-names></name> (<year>2011</year>) <article-title>The effect of caloric restriction and glycemic load on measures of oxidative stress and antioxidants in humans: results from the CALERIE Trial of Human Caloric Restriction</article-title>. <source>J Nutr Health Aging</source>
<volume>15</volume>: <fpage>456</fpage>&#x02013;<lpage>460</lpage>.<pub-id pub-id-type="pmid">21623467</pub-id></mixed-citation></ref><ref id="pone.0047079-1"><label>18</label><mixed-citation publication-type="journal">
<article-title>National Health and Nutrition Examination Survey (NHANES): Anthropometry Procedures Manual</article-title>. In: <name><surname>Prevention</surname><given-names>CfDCa</given-names></name>, editor. Atlanta, GA: CDC. <source>3: 20&#x02013;23 and</source>
<volume>23</volume>: <fpage>30</fpage>&#x02013;<lpage>21</lpage>.</mixed-citation></ref><ref id="pone.0047079-Weir1"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Weir</surname><given-names>J</given-names></name> (<year>1949</year>) <article-title>New methods for calculating metabolic rate with special reference to protein metabolism</article-title>. <source>The Journal of Physiology</source>
<volume>109</volume>: <fpage>1</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">15394301</pub-id></mixed-citation></ref><ref id="pone.0047079-Miller1"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Miller</surname><given-names>PE</given-names></name>, <name><surname>Mitchell</surname><given-names>DC</given-names></name>, <name><surname>Harala</surname><given-names>PL</given-names></name>, <name><surname>Pettit</surname><given-names>JM</given-names></name>, <name><surname>Smiciklas-Wright</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Development and evaluation of a method for calculating the Healthy Eating Index-2005 using the Nutrition Data System for Research</article-title>. <source>Public Health Nutrition</source>
<volume>14</volume>: <fpage>306</fpage>&#x02013;<lpage>313</lpage>.<pub-id pub-id-type="pmid">20576195</pub-id></mixed-citation></ref><ref id="pone.0047079-Harnack1"><label>21</label><mixed-citation publication-type="other">Harnack L, Stevens M, Van H, Schakel S, Dwyer J, <etal>et al</etal>. (2008) A computer-based approach for assessing dietary supplement use in conjunction with dietary recalls. J Food Compost Anal 21 (Supplement): S78&#x02013;S82.</mixed-citation></ref><ref id="pone.0047079-Bingham1"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Bingham</surname><given-names>S</given-names></name>, <name><surname>Cummings</surname><given-names>J</given-names></name> (<year>1985</year>) <article-title>Urine nitrogen as an independent validatory measure of dietary intake: a study of nitrogen balance in individuals consuming their normal diet</article-title>. <source>The American Journal of Clinical Nutrition</source>
<volume>42</volume>: <fpage>1276</fpage>&#x02013;<lpage>1289</lpage>.<pub-id pub-id-type="pmid">4072961</pub-id></mixed-citation></ref><ref id="pone.0047079-McCullough1"><label>23</label><mixed-citation publication-type="journal">
<name><surname>McCullough</surname><given-names>ML</given-names></name>, <name><surname>Swain</surname><given-names>JF</given-names></name>, <name><surname>Malarick</surname><given-names>C</given-names></name>, <name><surname>Moore</surname><given-names>TJ</given-names></name> (<year>1991</year>) <article-title>Feasibility of outpatient electrolyte balance studies</article-title>. <source>Journal of the American College of Nutrition</source>
<volume>10</volume>: <fpage>140</fpage>&#x02013;<lpage>148</lpage>.<pub-id pub-id-type="pmid">2030256</pub-id></mixed-citation></ref><ref id="pone.0047079-Feskanich1"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Feskanich</surname><given-names>D</given-names></name>, <name><surname>Sielaff</surname><given-names>BH</given-names></name>, <name><surname>Chong</surname><given-names>K</given-names></name>, <name><surname>Buzzard</surname><given-names>IM</given-names></name> (<year>1989</year>) <article-title>Computerized collection and analysis of dietary intake information</article-title>. <source>Comput Methods Programs Biomed</source>
<volume>30</volume>: <fpage>47</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">2582746</pub-id></mixed-citation></ref><ref id="pone.0047079-Johnson1"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Johnson</surname><given-names>RK</given-names></name>, <name><surname>Driscoll</surname><given-names>P</given-names></name>, <name><surname>Goran</surname><given-names>MI</given-names></name> (<year>1996</year>) <article-title>Comparison of multiple-pass 24-hour recall estimates of energy intake with total energy expenditure determined by the doubly labeled water method in young children</article-title>. <source>J Am Diet Assoc</source>
<volume>96</volume>: <fpage>1140</fpage>&#x02013;<lpage>1144</lpage>.<pub-id pub-id-type="pmid">8906138</pub-id></mixed-citation></ref><ref id="pone.0047079-Morrow1"><label>26</label><mixed-citation publication-type="journal">
<collab>Morrow JD, Roberts LJ 2nd</collab> (<year>1999</year>) <article-title>Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress</article-title>. <source>Methods in enzymology</source>
<volume>300</volume>: <fpage>3</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">9919502</pub-id></mixed-citation></ref><ref id="pone.0047079-Kadiiska1"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Kadiiska</surname><given-names>MB</given-names></name>, <name><surname>Gladen</surname><given-names>BC</given-names></name>, <name><surname>Baird</surname><given-names>DD</given-names></name>, <name><surname>Germolec</surname><given-names>D</given-names></name>, <name><surname>Graham</surname><given-names>LB</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning</article-title>? <source>Free Radical Biology and Medicine</source>
<volume>38</volume>: <fpage>698</fpage>&#x02013;<lpage>710</lpage>.<pub-id pub-id-type="pmid">15721980</pub-id></mixed-citation></ref><ref id="pone.0047079-Milne1"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Milne</surname><given-names>GL</given-names></name>, <name><surname>Musiek</surname><given-names>ES</given-names></name>, <name><surname>Morrow</surname><given-names>JD</given-names></name> (<year>2005</year>) <article-title>F2-Isoprostanes as markers of oxidative stress in vivo: An overview</article-title>. <source>Biomarkers</source>
<volume>10</volume>: <fpage>10</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">16097390</pub-id></mixed-citation></ref><ref id="pone.0047079-Morrow2"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Morrow</surname><given-names>JD</given-names></name>, <name><surname>Hill</surname><given-names>KE</given-names></name>, <name><surname>Burk</surname><given-names>RF</given-names></name>, <name><surname>Nammour</surname><given-names>TM</given-names></name>, <name><surname>Badr</surname><given-names>KF</given-names></name>, <etal>et al</etal> (<year>1990</year>) <article-title>A Series of Prostaglandin F2-Like Compounds are Produced in vivo in Humans by a Non-Cyclooxygenase, Free Radical-Catalyzed Mechanism</article-title>. <source>PNAS</source>
<volume>87</volume>: <fpage>9383</fpage>&#x02013;<lpage>9387</lpage>.<pub-id pub-id-type="pmid">2123555</pub-id></mixed-citation></ref><ref id="pone.0047079-Milne2"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Milne</surname><given-names>GL</given-names></name>, <name><surname>Yin</surname><given-names>H</given-names></name>, <name><surname>Hardy</surname><given-names>KD</given-names></name>, <name><surname>Davies</surname><given-names>SS</given-names></name>, <name><surname>Roberts</surname><given-names>LJ</given-names></name> (<year>2011</year>) <article-title>Isoprostane Generation and Function</article-title>. <source>Chemical Reviews</source>
<volume>111</volume>: <fpage>5973</fpage>&#x02013;<lpage>5996</lpage>.<pub-id pub-id-type="pmid">21848345</pub-id></mixed-citation></ref><ref id="pone.0047079-Chevion1"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Chevion</surname><given-names>M</given-names></name>, <name><surname>Berenshtein</surname><given-names>E</given-names></name>, <name><surname>Stadtman</surname><given-names>ER</given-names></name> (<year>2000</year>) <article-title>Human studies related to protein oxidation: protein carbonyl content as a marker of damage</article-title>. <source>Free Radic Res</source>
<volume>33</volume>
<issue>Suppl</issue>: <fpage>S99</fpage>&#x02013;<lpage>108</lpage>
<pub-id pub-id-type="pmid">11191280</pub-id></mixed-citation></ref><ref id="pone.0047079-Dizdaroglu1"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Dizdaroglu</surname><given-names>M</given-names></name>, <name><surname>Nackerdien</surname><given-names>Z</given-names></name>, <name><surname>Chao</surname><given-names>BC</given-names></name>, <name><surname>Gajewski</surname><given-names>E</given-names></name>, <name><surname>Rao</surname><given-names>G</given-names></name> (<year>1991</year>) <article-title>Chemical nature of in vivo DNA base damage in hydrogen peroxide-treated mammalian cells</article-title>. <source>Arch Biochem Biophys</source>
<volume>285</volume>: <fpage>388</fpage>&#x02013;<lpage>390</lpage>.<pub-id pub-id-type="pmid">1654775</pub-id></mixed-citation></ref><ref id="pone.0047079-Koizumi1"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Koizumi</surname><given-names>A</given-names></name>, <name><surname>Weindruch</surname><given-names>R</given-names></name>, <name><surname>Walford</surname><given-names>RL</given-names></name> (<year>1987</year>) <article-title>Influences of dietary restriction and age on liver enzyme activities and lipid peroxidation in mice</article-title>. <source>J Nutr</source>
<volume>117</volume>: <fpage>361</fpage>&#x02013;<lpage>367</lpage>.<pub-id pub-id-type="pmid">3031254</pub-id></mixed-citation></ref><ref id="pone.0047079-Rao1"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Rao</surname><given-names>G</given-names></name>, <name><surname>Xia</surname><given-names>E</given-names></name>, <name><surname>Nadakavukaren</surname><given-names>MJ</given-names></name>, <name><surname>Richardson</surname><given-names>A</given-names></name> (<year>1990</year>) <article-title>Effect of dietary restriction on the age-dependent changes in the expression of antioxidant enzymes in rat liver</article-title>. <source>J Nutr</source>
<volume>120</volume>: <fpage>602</fpage>&#x02013;<lpage>609</lpage>.<pub-id pub-id-type="pmid">2352034</pub-id></mixed-citation></ref><ref id="pone.0047079-Gomi1"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Gomi</surname><given-names>F</given-names></name>, <name><surname>Matsuo</surname><given-names>M</given-names></name> (<year>1998</year>) <article-title>Effects of aging and food restriction on the antioxidant enzyme activity of rat livers</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>
<volume>53</volume>: <fpage>B161</fpage>&#x02013;<lpage>167</lpage>.<pub-id pub-id-type="pmid">9597038</pub-id></mixed-citation></ref><ref id="pone.0047079-Sohal1"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Sohal</surname><given-names>RS</given-names></name>, <name><surname>Weindruch</surname><given-names>R</given-names></name> (<year>1996</year>) <article-title>Oxidative stress, caloric restriction, and aging</article-title>. <source>Science</source>
<volume>273</volume>: <fpage>59</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">8658196</pub-id></mixed-citation></ref><ref id="pone.0047079-Redman1"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Redman</surname><given-names>LM</given-names></name>, <name><surname>Ravussin</surname><given-names>E</given-names></name> (<year>2011</year>) <article-title>Caloric restriction in humans: impact on physiological, psychological, and behavioral outcomes</article-title>. <source>Antioxid Redox Signal</source>
<volume>14</volume>: <fpage>275</fpage>&#x02013;<lpage>287</lpage>.<pub-id pub-id-type="pmid">20518700</pub-id></mixed-citation></ref><ref id="pone.0047079-Heilbronn1"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Heilbronn</surname><given-names>LK</given-names></name>, <name><surname>de Jonge</surname><given-names>L</given-names></name>, <name><surname>Frisard</surname><given-names>MI</given-names></name>, <name><surname>DeLany</surname><given-names>JP</given-names></name>, <name><surname>Larson-Meyer</surname><given-names>DE</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial</article-title>. <source>JAMA</source>
<volume>295</volume>: <fpage>1539</fpage>&#x02013;<lpage>1548</lpage>.<pub-id pub-id-type="pmid">16595757</pub-id></mixed-citation></ref><ref id="pone.0047079-Yagi1"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Yagi</surname><given-names>K</given-names></name> (<year>1976</year>) <article-title>A simple fluorometric assay for lipoperoxide in blood plasma</article-title>. <source>Biochem Med</source>
<volume>15</volume>: <fpage>212</fpage>&#x02013;<lpage>216</lpage>.<pub-id pub-id-type="pmid">962904</pub-id></mixed-citation></ref><ref id="pone.0047079-Davi1"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Davi</surname><given-names>G</given-names></name>, <name><surname>Guagnano</surname><given-names>MT</given-names></name>, <name><surname>Ciabattoni</surname><given-names>G</given-names></name>, <name><surname>Basili</surname><given-names>S</given-names></name>, <name><surname>Falco</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Platelet Activation in Obese Women: Role of Inflammation and Oxidant Stress</article-title>. <source>JAMA</source>
<volume>288</volume>: <fpage>2008</fpage>&#x02013;<lpage>2014</lpage>.<pub-id pub-id-type="pmid">12387653</pub-id></mixed-citation></ref><ref id="pone.0047079-Tsai1"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Tsai</surname><given-names>IJ</given-names></name>, <name><surname>Croft</surname><given-names>KD</given-names></name>, <name><surname>Mori</surname><given-names>TA</given-names></name>, <name><surname>Falck</surname><given-names>JR</given-names></name>, <name><surname>Beilin</surname><given-names>LJ</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction</article-title>. <source>Free Radical Biology and Medicine</source>
<volume>46</volume>: <fpage>263</fpage>&#x02013;<lpage>270</lpage>.<pub-id pub-id-type="pmid">19013235</pub-id></mixed-citation></ref><ref id="pone.0047079-Roberts1"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Roberts</surname><given-names>LJ</given-names></name>, <name><surname>Morrow</surname><given-names>JD</given-names></name> (<year>2000</year>) <article-title>Measurement of F2-isoprostanes as an index of oxidative stress in vivo</article-title>. <source>Free Radical Biology and Medicine</source>
<volume>28</volume>: <fpage>505</fpage>.<pub-id pub-id-type="pmid">10719231</pub-id></mixed-citation></ref><ref id="pone.0047079-Ridker1"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Ridker</surname><given-names>PM</given-names></name>, <name><surname>Rifai</surname><given-names>N</given-names></name>, <name><surname>Clearfield</surname><given-names>M</given-names></name>, <name><surname>Downs</surname><given-names>JR</given-names></name>, <name><surname>Weis</surname><given-names>SE</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events</article-title>. <source>N Engl J Med</source>
<volume>344</volume>: <fpage>1959</fpage>&#x02013;<lpage>1965</lpage>.<pub-id pub-id-type="pmid">11430324</pub-id></mixed-citation></ref><ref id="pone.0047079-Richelle1"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Richelle</surname><given-names>M</given-names></name>, <name><surname>Turini</surname><given-names>ME</given-names></name>, <name><surname>Guidoux</surname><given-names>R</given-names></name>, <name><surname>Tavazzi</surname><given-names>I</given-names></name>, <name><surname>M&#x000e9;tairon</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Urinary isoprostane excretion is not confounded by the lipid content of the diet</article-title>. <source>FEBS Letters</source>
<volume>459</volume>: <fpage>259</fpage>&#x02013;<lpage>262</lpage>.<pub-id pub-id-type="pmid">10518031</pub-id></mixed-citation></ref><ref id="pone.0047079-Gopaul1"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Gopaul</surname><given-names>N</given-names></name>, <name><surname>Halliwell</surname><given-names>B</given-names></name>, <name><surname>Angg&#x000e5;rd</surname><given-names>E</given-names></name> (<year>2000</year>) <article-title>Measurement of plasma F2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet</article-title>. <source>Free Radic Res</source>
<volume>33</volume>: <fpage>115</fpage>&#x02013;<lpage>127</lpage>.<pub-id pub-id-type="pmid">10885619</pub-id></mixed-citation></ref><ref id="pone.0047079-CodoerFranch1"><label>46</label><mixed-citation publication-type="other">Codo&#x000f1;er-Franch P, Valls-Bell&#x000e9;s V, Arilla-Codo&#x000f1;er A, Alonso-Iglesias E Oxidant mechanisms in childhood obesity: the link between inflammation and oxidative stress. Translational Research.</mixed-citation></ref><ref id="pone.0047079-TsaiWC1"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Tsai WC</surname><given-names>LY</given-names></name>, <name><surname>Lin</surname><given-names>CC</given-names></name>, <name><surname>Chao</surname><given-names>TH</given-names></name>, <name><surname>Chen</surname><given-names>JH</given-names></name> (<year>2004</year>) <article-title>Effects of oxidative stress on endothelial function after a high-fat meal</article-title>. <source>Clin Science</source>
<volume>106</volume>: <fpage>315</fpage>&#x02013;<lpage>319</lpage>.</mixed-citation></ref><ref id="pone.0047079-Bae1"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Bae</surname><given-names>J-H</given-names></name>, <name><surname>Bassenge</surname><given-names>E</given-names></name>, <name><surname>Kim</surname><given-names>K-B</given-names></name>, <name><surname>Kim</surname><given-names>Y-N</given-names></name>, <name><surname>Kim</surname><given-names>K-S</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress</article-title>. <source>Atherosclerosis</source>
<volume>155</volume>: <fpage>517</fpage>.<pub-id pub-id-type="pmid">11254924</pub-id></mixed-citation></ref><ref id="pone.0047079-Ziccardi1"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Ziccardi</surname><given-names>P</given-names></name>, <name><surname>Nappo</surname><given-names>F</given-names></name>, <name><surname>Giugliano</surname><given-names>G</given-names></name>, <name><surname>Esposito</surname><given-names>K</given-names></name>, <name><surname>Marfella</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year</article-title>. <source>Circulation</source>
<volume>105</volume>: <fpage>804</fpage>&#x02013;<lpage>809</lpage>.<pub-id pub-id-type="pmid">11854119</pub-id></mixed-citation></ref><ref id="pone.0047079-Wray1"><label>50</label><mixed-citation publication-type="other">Wray DW, Nishiyama SK, Donato AJ, Carlier P, Bailey DM, <etal>et al</etal>. (2011) The Paradox of Oxidative Stress and Exercise With Advancing Age. Exercise and Sport Sciences Reviews 39: 68&#x02013;76 10.1097/JES.1090b1013e31820d37657.</mixed-citation></ref><ref id="pone.0047079-Higdon1"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Higdon</surname><given-names>JV</given-names></name>, <name><surname>Frei</surname><given-names>B</given-names></name> (<year>2003</year>) <article-title>Obesity and Oxidative Stress: A Direct Link to CVD</article-title>? <source>Arterioscler Thromb Vasc Biol</source>
<volume>23</volume>: <fpage>365</fpage>&#x02013;<lpage>367</lpage>.<pub-id pub-id-type="pmid">12639823</pub-id></mixed-citation></ref><ref id="pone.0047079-Heilbronn2"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Heilbronn</surname><given-names>L</given-names></name>, <name><surname>Civitarese</surname><given-names>AE</given-names></name>, <name><surname>Bogacka</surname><given-names>I</given-names></name>, <name><surname>Smith</surname><given-names>S</given-names></name>, <name><surname>Hulver</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting</article-title>. <source>Obes Res</source>
<volume>13</volume>: <fpage>574</fpage>&#x02013;<lpage>581</lpage>.<pub-id pub-id-type="pmid">15833943</pub-id></mixed-citation></ref><ref id="pone.0047079-Hall1"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Hall</surname><given-names>KD</given-names></name>, <name><surname>Jordan</surname><given-names>PN</given-names></name> (<year>2008</year>) <article-title>Modeling weight-loss maintenance to help prevent body weight regain</article-title>. <source>The American Journal of Clinical Nutrition</source>
<volume>88</volume>: <fpage>1495</fpage>&#x02013;<lpage>1503</lpage>.<pub-id pub-id-type="pmid">19064508</pub-id></mixed-citation></ref><ref id="pone.0047079-Strychar1"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Strychar</surname><given-names>I</given-names></name>, <name><surname>Lavoie</surname><given-names>M-&#x000c8;</given-names></name>, <name><surname>Messier</surname><given-names>L</given-names></name>, <name><surname>Karelis</surname><given-names>AD</given-names></name>, <name><surname>Doucet</surname><given-names>&#x000c9;</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Anthropometric, Metabolic, Psychosocial, and Dietary Characteristics of Overweight/Obese Postmenopausal Women with a History of Weight Cycling: A MONET (Montreal Ottawa New Emerging Team) Study</article-title>. <source>Journal of the American Dietetic Association</source>
<volume>109</volume>: <fpage>718</fpage>&#x02013;<lpage>724</lpage>.<pub-id pub-id-type="pmid">19328269</pub-id></mixed-citation></ref><ref id="pone.0047079-Pieper1"><label>55</label><mixed-citation publication-type="journal">
<name><surname>Pieper</surname><given-names>C</given-names></name>, <name><surname>Redman</surname><given-names>L</given-names></name>, <name><surname>Racette</surname><given-names>S</given-names></name>, <name><surname>Roberts</surname><given-names>S</given-names></name>, <name><surname>Bhapkar</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Development of adherence metrics for caloric restriction interventions</article-title>. <source>Clin Trials</source>
<volume>8</volume>: <fpage>155</fpage>&#x02013;<lpage>164</lpage>.<pub-id pub-id-type="pmid">21385788</pub-id></mixed-citation></ref><ref id="pone.0047079-Field1"><label>56</label><mixed-citation publication-type="journal">
<name><surname>Field</surname><given-names>AE</given-names></name>, <name><surname>Manson</surname><given-names>JE</given-names></name>, <name><surname>Taylor</surname><given-names>CB</given-names></name>, <name><surname>Willett</surname><given-names>WC</given-names></name>, <name><surname>Colditz</surname><given-names>GA</given-names></name> (<year>2004</year>) <article-title>Association of weight change, weight control practices, and weight cycling among women in the Nurses' Health Study II</article-title>. <source>International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity</source>
<volume>28</volume>: <fpage>1134</fpage>&#x02013;<lpage>1142</lpage>.</mixed-citation></ref><ref id="pone.0047079-LahtiKoski1"><label>57</label><mixed-citation publication-type="journal">
<name><surname>Lahti-Koski</surname><given-names>M</given-names></name>, <name><surname>Mannisto</surname><given-names>S</given-names></name>, <name><surname>Pietinen</surname><given-names>P</given-names></name>, <name><surname>Vartiainen</surname><given-names>E</given-names></name> (<year>2005</year>) <article-title>Prevalence of weight cycling and its relation to health indicators in Finland</article-title>. <source>Obes Res</source>
<volume>13</volume>: <fpage>333</fpage>&#x02013;<lpage>341</lpage>.<pub-id pub-id-type="pmid">15800292</pub-id></mixed-citation></ref><ref id="pone.0047079-Osborn1"><label>58</label><mixed-citation publication-type="journal">
<name><surname>Osborn</surname><given-names>R</given-names></name>, <name><surname>Forys</surname><given-names>K</given-names></name>, <name><surname>Psota</surname><given-names>T</given-names></name>, <name><surname>Sbrocco</surname><given-names>T</given-names></name> (<year>2011</year>) <article-title>Yo-yo dieting in African American women: weight cycling and health</article-title>. <source>Ethn Dis</source>
<volume>21</volume>: <fpage>274</fpage>&#x02013;<lpage>280</lpage>.<pub-id pub-id-type="pmid">21942158</pub-id></mixed-citation></ref><ref id="pone.0047079-Cereda1"><label>59</label><mixed-citation publication-type="journal">
<name><surname>Cereda</surname><given-names>E</given-names></name>, <name><surname>Malavazos</surname><given-names>AE</given-names></name>, <name><surname>Caccialanza</surname><given-names>R</given-names></name>, <name><surname>Rondanelli</surname><given-names>M</given-names></name>, <name><surname>Fatati</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Weight cycling is associated with body weight excess and abdominal fat accumulation: A cross-sectional study</article-title>. <source>Clinical Nutrition</source>
<volume>30</volume>: <fpage>718</fpage>&#x02013;<lpage>723</lpage>.<pub-id pub-id-type="pmid">21764186</pub-id></mixed-citation></ref><ref id="pone.0047079-Dulloo1"><label>60</label><mixed-citation publication-type="journal">
<name><surname>Dulloo</surname><given-names>AG</given-names></name>, <name><surname>Jacquet</surname><given-names>J</given-names></name>, <name><surname>Montani</surname><given-names>J-P</given-names></name> (<year>2012</year>) <article-title>How dieting makes some fatter: from a perspective of human body composition autoregulation</article-title>. <source>Proceedings of the Nutrition Society</source>
<volume>71</volume>: <fpage>379</fpage>&#x02013;<lpage>389</lpage>.<pub-id pub-id-type="pmid">22475574</pub-id></mixed-citation></ref><ref id="pone.0047079-Hooper1"><label>61</label><mixed-citation publication-type="journal">
<name><surname>Hooper</surname><given-names>LE</given-names></name>, <name><surname>Foster-Schubert</surname><given-names>KE</given-names></name>, <name><surname>Weigle</surname><given-names>DS</given-names></name>, <name><surname>Sorensen</surname><given-names>B</given-names></name>, <name><surname>Ulrich</surname><given-names>CM</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Frequent intentional weight loss is associated with higher ghrelin and lower glucose and androgen levels in postmenopausal women</article-title>. <source>Nutrition Research</source>
<volume>30</volume>: <fpage>163</fpage>&#x02013;<lpage>170</lpage>.<pub-id pub-id-type="pmid">20417876</pub-id></mixed-citation></ref><ref id="pone.0047079-Graci1"><label>62</label><mixed-citation publication-type="journal">
<name><surname>Graci</surname><given-names>S</given-names></name>, <name><surname>Izzo</surname><given-names>G</given-names></name>, <name><surname>Savino</surname><given-names>S</given-names></name>, <name><surname>Cattani</surname><given-names>L</given-names></name>, <name><surname>Lezzi</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Weight cycling and cardiovascular risk factors in obesity</article-title>. <source>International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity</source>
<volume>28</volume>: <fpage>65</fpage>&#x02013;<lpage>71</lpage>.</mixed-citation></ref><ref id="pone.0047079-Stevens1"><label>63</label><mixed-citation publication-type="journal">
<name><surname>Stevens</surname><given-names>VL</given-names></name>, <name><surname>Jacobs</surname><given-names>EJ</given-names></name>, <name><surname>Sun</surname><given-names>J</given-names></name>, <name><surname>Patel</surname><given-names>AV</given-names></name>, <name><surname>McCullough</surname><given-names>ML</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Weight Cycling and Mortality in a Large Prospective US Study</article-title>. <source>American Journal of Epidemiology</source>
<volume>175</volume>: <fpage>785</fpage>&#x02013;<lpage>792</lpage>.<pub-id pub-id-type="pmid">22287640</pub-id></mixed-citation></ref><ref id="pone.0047079-Hooper2"><label>64</label><mixed-citation publication-type="journal">
<name><surname>Hooper</surname><given-names>LE</given-names></name>, <name><surname>Foster-Schubert</surname><given-names>KE</given-names></name>, <name><surname>Weigle</surname><given-names>DS</given-names></name>, <name><surname>Sorensen</surname><given-names>B</given-names></name>, <name><surname>Ulrich</surname><given-names>CM</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Frequent intentional weight loss is associated with higher ghrelin and lower glucose and androgen levels in postmenopausal women</article-title>. <source>Nutr Res</source>
<volume>30</volume>: <fpage>163</fpage>&#x02013;<lpage>170</lpage>.<pub-id pub-id-type="pmid">20417876</pub-id></mixed-citation></ref><ref id="pone.0047079-Institute1"><label>65</label><mixed-citation publication-type="other">Institute of Medicine (2000) Panel on Dietary Antioxidants and Related Compounds: Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, D.C.: National Academy Press. 506 p. p.</mixed-citation></ref><ref id="pone.0047079-Heilbronn3"><label>66</label><mixed-citation publication-type="journal">
<name><surname>Heilbronn</surname><given-names>L</given-names></name>, <name><surname>Ravussin</surname><given-names>E</given-names></name> (<year>2003</year>) <article-title>Caloric restriction and aging: review of the literature and implications for studies in humans</article-title>. <source>The American Journal of Clinical Nutrition</source>
<volume>78</volume>: <fpage>361</fpage>&#x02013;<lpage>369</lpage>.<pub-id pub-id-type="pmid">12936916</pub-id></mixed-citation></ref><ref id="pone.0047079-Davalos1"><label>67</label><mixed-citation publication-type="journal">
<name><surname>Davalos</surname><given-names>A</given-names></name>, <name><surname>Gomez-Cordoves</surname><given-names>C</given-names></name>, <name><surname>Bartolome</surname><given-names>B</given-names></name> (<year>2004</year>) <article-title>Extending applicability of the oxygen radical absorbance capacity (ORAC-fluorescein) assay</article-title>. <source>J Agric Food Chem</source>
<volume>52</volume>: <fpage>48</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">14709012</pub-id></mixed-citation></ref><ref id="pone.0047079-Apak1"><label>68</label><mixed-citation publication-type="journal">
<name><surname>Apak</surname><given-names>R</given-names></name>, <name><surname>Guclu</surname><given-names>K</given-names></name>, <name><surname>Ozyurek</surname><given-names>M</given-names></name>, <name><surname>Bektasoglu</surname><given-names>B</given-names></name>, <name><surname>Bener</surname><given-names>M</given-names></name> (<year>2010</year>) <article-title>Cupric ion reducing antioxidant capacity assay for antioxidants in human serum and for hydroxyl radical scavengers</article-title>. <source>Methods Mol Biol</source>
<volume>594</volume>: <fpage>215</fpage>&#x02013;<lpage>239</lpage>.<pub-id pub-id-type="pmid">20072920</pub-id></mixed-citation></ref><ref id="pone.0047079-Nemzer1"><label>69</label><mixed-citation publication-type="journal">
<name><surname>Nemzer</surname><given-names>BV</given-names></name>, <name><surname>Rodriguez</surname><given-names>LC</given-names></name>, <name><surname>Hammond</surname><given-names>L</given-names></name>, <name><surname>Disilvestro</surname><given-names>R</given-names></name>, <name><surname>Hunter</surname><given-names>JM</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Acute reduction of serum 8-iso-PGF2-alpha and advanced oxidation protein products in vivo by a polyphenol-rich beverage; a pilot clinical study with phytochemical and in vitro antioxidant characterization</article-title>. <source>Nutr J</source>
<volume>10</volume>: <fpage>67</fpage>.<pub-id pub-id-type="pmid">21676230</pub-id></mixed-citation></ref><ref id="pone.0047079-Wray2"><label>70</label><mixed-citation publication-type="journal">
<name><surname>Wray</surname><given-names>DW</given-names></name>, <name><surname>Nishiyama</surname><given-names>SK</given-names></name>, <name><surname>Harris</surname><given-names>RA</given-names></name>, <name><surname>Zhao</surname><given-names>J</given-names></name>, <name><surname>McDaniel</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption</article-title>. <source>Hypertension</source>
<volume>59</volume>: <fpage>818</fpage>&#x02013;<lpage>824</lpage>.<pub-id pub-id-type="pmid">22353612</pub-id></mixed-citation></ref></ref-list></back></article>